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     The incidence of obesity is increasing worldwide, currently affecting over 400 million 
people.  With obesity, expansion of white adipose tissue (WAT) contributes to a chronic, 
low-grade inflammatory response that is associated with the formation of complications 
such as type 2 diabetes, cardiovascular disease, and hypertension.  One potential method 
of reducing chronic inflammation associated with obesity is through consumption of table 
grapes, which contain fiber and are rich in phytochemicals with potential health 
promoting properties.  Several clinical trials and animal studies have demonstrated that 
consumption of grape products (i.e. grape seed extract, grape juice, or California 
powdered table grapes) can reduce oxidative stress, insulin resistance, and inflammation, 
as well as improve heart health.  However, there is still much to be elucidated concerning 
the mechanisms by which grapes or grape products exert beneficial effects and which 
compounds within grapes are active in the mediation of these effects.  Additionally, the 
influence of grape polyphenols and fiber on gut microbiota and the link of this with 
improvements in adiposity, systemic inflammation and insulin resistance are unclear.   
     Therefore, the specific aims of this research were to (i) determine the extent to which 
California table grapes attenuate body fat accumulation, systemic inflammation, and 
insulin resistance, and impact gut microbiota in mice fed and American type diet rich in
butter (Aim 1), and (ii) identify the key bioactive fraction(s) responsible for reducing 
adiposity, inflammation, and insulin resistance, and modulating gut microbiota in mice 
fed an American-type diet rich in four types of saturated fat (Aim 2).  In Aim 1, grape 
consumption at one or both levels (i.e. 3% or 5% w/w) attenuated accumulation of body 
and liver fat, but these lipid lowering effects were not associated in improvements in 
glucose tolerance or markers of inflammation in WAT.  Alterations in microbial species 
(i.e. reductions in deleterious sulfidogenic bacteria and increases in beneficial bacteria) 
were observed in grape-fed mice. Taken together these data demonstrate that consuming 
grapes results in attenuations in adiposity and hepatic steatosis, and also alterations gut 
microbial populations in mice fed a butter-rich diet.  In Aim 2, consumption of the 
extractable polyphenol fraction (EP) alone or with the non-extractable polyphenol 
fraction (EP+NEP), but not powdered grapes (GP), reduced adiposity, liver and plasma 
triglycerides, markers of inflammation within WAT, and improved insulin sensitivity in 
mice fed a diet rich in saturated fat from four sources.  Taken together, these data 
demonstrate that (i) consumption of polyphenols extracted from powdered grapes is 
effective at preventing the complications of diet-induced obesity, and that (ii) the effects 
of powdered grapes differ based on the amount and source of dietary fat. Overall, the 
findings from Aim 1 and Aim 2 are anticipated to contribute to the development of novel 
dietary strategies using grapes or grape products to manage or treat diet-induced obesity 
and associated conditions.  Further research studies, including clinical trials, are still 
warranted to determine the applicability of these findings to the human population.
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     Obesity is a global health condition with approximately 400 million people classified 
as obese and 1.6 billion overweight [1]. The sharp rise in obesity is paralleled by similar 
increases in the incidence of cardiovascular disease (CVD), hypertension, and type 2 
diabetes, all of which are associated with chronic, low-grade inflammation [2]. These 
obesity-related conditions are referred to as the metabolic syndrome.  Primary causes of 
obesity are overconsumption of diets rich in fat, refined carbohydrates, and sugars, and 
lack of physical activity.   
     One potential way to reduce chronic inflammation associated with diet-induced 
obesity is to consume table grapes.  Grapes contain fiber and phytochemicals with 
potential health-promoting properties [reviewed in 3].  For example, several clinical trials 
have demonstrated that consuming grape seed extract, grape juice, or California 
powdered table grapes decreased oxidative stress and inflammatory markers within blood 
[4, 5, 6]. It has also been demonstrated that consumption of grape seed extract decreased 
colon cancer in mice [7]. Additionally, our lab group has shown that California table 
grape supplementation decreased insulin resistance acutely, and systemic inflammation 
chronically, but not adiposity in mice fed an extremely high fat, lard-based diet [8].
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However, the extent to which California table grapes reduce adiposity, systemic 
inflammation, and insulin resistance in mice fed an American type diet rich in saturated 
fat, and their mechanism of action including their potential prebiotic actions, have not yet 
been reported. 
 
Central Hypothesis and Specific Aims 
     This thesis is a part of a continuing project with the long-term goal of developing 
novel approaches to prevent or treat obesity and its metabolic consequences using table 
grapes.  The central hypothesis of my thesis research was that California table grapes, 
and one or more of their bioactive fractions or components, would decrease adiposity, 
systemic inflammation, and insulin resistance associated with diet-induced obesity.  I 
predicted these beneficial systemic outcomes would be due, in part, to modulation of the 
gut microbiota and subsequent improvements in intestinal health. The working model 
showing how grapes exert these effects is shown in Figure 1.1.   
     To test my central hypothesis, the following specific aims were pursued:  
     Aim #1. Determine the extent to which California table grapes attenuate body fat 
accumulation, systemic inflammation, and insulin resistance, as well as impact gut 
microbiota in mice fed an American type diet rich in saturated fat from butter; and  
     Aim #2. Identify the key bioactive fractions in California table grapes responsible for 
reducing adiposity, inflammation, and insulin resistance, and modulating gut microbiota 




The expected outcomes of these aims were as follows: 
     Aim #1. I expected that whole powdered grapes would reduce adiposity, systemic          
markers of inflammation, and insulin resistance, which would be due, in part, to its pre- 
or postbiotic actions.   
     Aim #2. I expected that the methanol-extractable, polyphenol-rich fraction of 
powdered grapes would elicit greater improvements in adiposity, inflammation, and 
insulin resistance compared to the non- extractable fraction due, in part, to beneficial 
alterations in gut microbiota and improvements in intestinal health.   
     This thesis was innovative and significant, because it was expected to identify novel 
mechanisms by which whole California table grapes alter gut microbiota and intestinal 
health that, in turn, cause reductions in systemic inflammation and insulin resistance.  
Such knowledge would provide great benefit to the medical community and the public by 
informing them about the pre- and postbiotic properties of California table grapes, the 






Figure 1.1. Proposed Model on how Table Grapes Attenuate the Development of 
Diet-Induced Obesity, Inflammatory Signaling, and Insulin Resistance.  As 
prebiotics, grape polyphenols enhance the abundance of healthy types of bacteria (e.g, 
Akkermansia muciniphila) that contribute to short chain fatty acid (SCFA) production 
and activation of G-protein receptors 41 and 43 (GPR41 and GPR43) resulting in 
suppression of complications associated with consuming a high fat diet (i.e. inflammation 
and metabolic syndrome).  Grape polyphenols also decrease the abundance of noxious 
bacteria (e.g., sulfidogenic bacteria) that impair gut barrier functions (i.e., cause leaky 
gut).  These improvements in barrier function prevent endotoxemia (i.e., increase LPS in 
the bloodstream)-mediated inflammatory gene expression systemically.  Alternatively, 
grape polyphenols reaching the blood stream may directly attenuate saturated FA 
mediated nutritional toxemia (e.g., saturated FA mediated TLR4/2 activation) that 
triggers white adipose tissue inflammation leading to metabolic syndrome.  Grape 
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polyphenols may also activate GPRs thereby activating adelylate cyclase (AC) and 5’ 
adenosine monophosphate kinase (AMPK) which increase lipolysis and fatty acid (FA) 
oxidation in turn attenuating adiposity, subsequent macrophage recruitment and reactive 
oxidant species (ROS), reactive nitrogen species (RNS), nitric oxide (NO), and hydrogen 
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REVIEW OF LITERATURE 
 
 
Obesity Epidemic and White Adipose Tissue (WAT)   
 
     Over the last few decades the incidence of obesity has increased drastically throughout 
the world.  Recent estimates indicate that there are greater than 1.45 billion overweight 
individuals worldwide, with approximately 500 million of these individuals being obese 
[1].  This rise in obesity has resulted in large increases in related health conditions such 
as type 2 diabetes, hypertension, hyperlipidemia, cardiovascular disease (CVD), and fatty 
liver disease [2].  Collectively, this group of obesity-related diseases has been referred to 
as the metabolic syndrome. Notably, the metabolic syndrome is intimately linked with 
chronic inflammation in WAT that contributes to systemic inflammation and insulin 
resistance [1].  
 
Relationship of Obesity and WAT Expansion to Inflammation  
     Increased adiposity is associated with a positive energy balance, resulting in adipocyte 
hyperplasia and hypertrophy. Adipocyte hypertrophy, in turn, activates oxidative stress 
and inflammatory signaling pathways [reviewed in 3].  Up-regulation of these pathways, 
in turn, impairs glucose and fatty acid uptake and lipid synthesis via inhibition of insulin 
signaling.  This inflammatory response has been linked to several specific pathways.   In
8 
 
adipocytes, in vitro and in vivo evidence indicates that oversupply of lipid results in up-
regulation of toll-like receptors (TLR2/TLR4), which in turn is associated with activation 
of stress-associated kinases such as c-Jun N-terminal kinase (JNK), mitogen activate 
protein kinase (MAPK) p38, extracellular signal-regulated kinase (ERK), protein kinase 
C (PKC), nuclear factor kappa B (NFκB), and activator protein (AP)-1 (aka cJun) 
resulting in transcription and translation of downstream proinflammatory peptides and 
proteins [4]. For example, TLR-4 deficient mice are protected against the obesity related 
pro-inflammatory effects of a high fat diet. Furthermore, TLR-4 deficient mice had 
reduced levels of cellular NFκB and circulating monocyte chemoattractant protein 
(MCP)-1 levels [5], demonstrating a linkage between fat-induced TLR activation and 
inflammation. Obesity has also been shown to activate the inflammasome, a cytosolic 
multi-protein complex in white adipose tissue (WAT), leading to insulin resistance and 
an increase in the inflammatory cytokine interleukin (IL)-1β [6].  It has also been shown 
that feeding C57BL/6J mice a high fat diet for 16 weeks increased the expression of 
genes related to inflammation within epididymal WAT, resulting in WAT apoptosis and 
remodeling [7]. 
 
Effect of Polyphenols on Inflammation and Obesity 
     Polyphenols are naturally occurring phytochemicals found in plants. They exhibit a 
wide range of biological activities, particularly suppressing inflammation and oxidative 
stress.  Polyphenols have been shown to act as antioxidants, reducing the levels of 
reactive oxygen species (ROS), reactive nitrogen species (RNS), hydrogen peroxide 
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(H2O2), and nitric oxide (NO) which in turn blocks the pro-inflammatory pathways 
within WAT including the NFκB, activator protein 1 (AP-1), and mitogen-activated 
protein kinase (MAPK) pathways [reviewed in 8].  Additionally, polyphenols may inhibit 
pro-oxidant associated oxidative damage and cell death through activation of nuclear 
factor erythroid 2 related factor 2 (Nfr2) leading to increases in expression of numerous 
antioxidant enzymes [9]. Polyphenols have also been shown to reduce insulin resistance, 
most notably due to the ability of attenuate inflammatory or pro-oxidant signals that 
impair insulin-stimulated glucose uptake.   Anti-inflammatory and anti-diabetic effects 
have been demonstrated for a wide range of polyphenols including curcumin from 
turmeric, epigallocatechin gallate (EGCG) from green tea, and resveratrol from wine, 
grapes, and berries [reviewed in 8].  Additionally, polyphenols have been shown to 
suppress lipogenesis and increase beta-oxidation via cAMP, AMPK, and SIRT1 
pathways, resulting in increased glucose and fatty acid oxidation [reviewed in 8, 10].  
The anti-inflammatory and anti-oxidant properties of polyphenols are depicted in Figure 
2.1.   
     While polyphenols have been observed to have many anti-oxidant and inflammatory 
actions systemically, and some studies indicate that these compounds may aid in the 
prevention or reduction of obesity, there is still much to be elucidated.  Many of the 
studies mentioned use individual polyphenols at pharmacological doses.  Therefore, there 
is a gap in the knowledge about the ability of whole foods consumed at more 
physiological levels to suppress inflammation and reduce adiposity.  Additionally, 
research has demonstrated that the bioavailability of many polyphenols is low [11].  
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Thus, microbes in the lower intestinal tract are exposed to these non-absorbed 
phytochemicals.  Such observations have caused many to speculate that the gut 
microbiome may play an important role in eliciting these beneficial effects of dietary 
polyphenols [12]. 
 
Influence of Gut Microbes on Obesity and Inflammation   
     Obesity is associated with alterations in gut microbiota. High-fat and high-caloric 
diets have been shown to increase Gram-negative bacterial colonization of the intestine, 
resulting in increased plasma lipopolysaccharide (LPS) levels associated with metabolic 
endotoxemia [12]. For example, obesity resulted in increases in the relative abundance of 
Firmicutes spp. (Gram negative) and the reduction of Bacteroidetes spp. (Gram positive) 
in the gut of genetically obese mice [13].  When examining fecal samples from lean and 
obese individuals, the ratio of Firmicutes to Bacteriodetes was greatest in the obese group 
[14].  Akkermansia muciniphila, a beneficial bacteria associated with mucin-degradation 
and improved gut barrier function, has been found to be greatly decreased in genetically 
and diet-induced obese mice.  Furthermore, prebiotic treatment with oligofructose 
restored the abundance of A. muciniphila, while also improving gut barrier integrity, 
reducing body weight gain, fat mass development, and fasting hyperglycemia [15].  It has 
also been demonstrated that supplementation of a polyphenol-rich cranberry extract 
results in increases in the abundance of A. muciniphila , which in turn was associated 
with protection from diet-induced obesity, insulin resistance, and intestinal inflammation 
in mice fed a high fat diet [16]. 
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     Recently, the linkage between consumption of a diet high in saturated fat and the 
prevalence of deleterious sulfate-reducing bacteria (SRB) has been explored.  For 
example, Apoa-1 knockout mice with increased adiposity and impaired glucose disposal 
and wild-type mice were fed a high-fat, lard-based diet (60% kcal from fat) for 25 weeks 
[17].  It was observed that compared to low-fat fed control mice, both genetic mouse 
models fed the high fat diet developed significant alterations in the microbial community 
within the gut.  These alterations included reductions in beneficial Bifidobacterium spp. 
and increased abundance of Desulfovibrionaceae [18], a group of SRB that produce 
hydrogen sulfide, a genotoxic gas causing gut barrier dysfunction and endotoxemia 
[reviewed in 19].   Additionally, feeding IL-10 knockout mice a high milk fat-based diet 
(37% kcal from butter fat) decreased populations of gut barrier-protective bacterial 
species and increased SRB [19].  This increase in SRB directly correlated with the degree 
of expression of markers of inflammatory bowel disease and gut inflammation.  These 
two studies revealed the drastic alterations in gut bacterial species, specifically increases 
in genotoxic SRB, with consumption of a diet rich in saturated fat [19]. 
 
Anti-inflammatory and Anti-obesogenic Properties of Grapes  
     Grape and specific components found in grapes have been shown to impact 
inflammation as well as gut microbiota.  Grapes are rich in polyphenols, particularly 
resveratrol and flavonoids.  The polyphenol content of grapes is shown in Table 1 
[reviewed in 20].  Resveratrol consumption has been shown to reduce adiposity and 
inflammation [21], as well as insulin resistance and diabetes [22].   Some of the 
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mechanisms behind these actions are thought to involve activation of sirtuin (SIRT1)1, 
and ERK and suppression of the TLR2/4 and NFkB pathways [23].   It has been observed 
that resveratrol increases fatty acid oxidation through increases in expression of carnitine 
palmitoyl transferase (CPT), which may be responsible for the reductions in adiposity 
discussed previously [24]. 
     Anthocyanidins are a group of flavonoids and are present in large amounts relative to 
other polyphenols in grapes.  These compounds are found attached to sugar groups, 
typically 3-O-glucosides, and are referred to as anthocyanins.  The most abundant 
anthocyanins in grapes are malvidin / malvidin 3-O-glucoside and cyanidin / cyanidin 3-
O-glucoside [reviewed in 20].  Cyanidin 3-O-glucoside has been shown to improve 
insulin sensitivity and hyperglycemia in diabetic mice through the down-regulation of 
retinol binding protein (RBP) 4 [24], improve obesity and triglyceride metabolism by 
regulating lipoprotein lipase activity in KK-Ay mice [25], and improve insulin resistance 
thorough regulation of GLUT4 gene expression [26]. In vitro, malvidin treatment of 
RAW264.7 macrophages attenuated LPS- induced NFκB and MAPK activation, reactive 
oxygen species production, and mitochondrial depolarization while stimulating Akt 
(protein kinase B) activation, which is associated with improved insulin-stimulated 
glucose uptake [27].  In vitro, 3T3-L1 preadipocytes exposed to anthocyanins resulted in 
dose-dependent reductions in triglyceride accumulation as well as reductions in gene and 
protein expression of the transcription factors liver x receptor alpha (LXRα), stearoyl 
regulatory element binding protein 1c (SREBP1c), peroxisome proliferator-activated 
receptor-gamma (PPARγ), and CAAT enhancer binding protein alpha (C/EBPα) and their 
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target genes associated with lipogenesis including fatty acid synthase (FAS), stearoyl 
CoA desaturase 1 (SCD1), acetyl CoA carboxylase (ACC) [28]. 
     In vivo, Zucker rats fed a high fat diet supplemented with grape seed procyanidins had 
lower WAT mRNA levels of tumor necrosis factor (TNF)α, IL-6, and C-reactive protein 
(CRP) and lower plasma levels of CRP compared to high-fat-fed control rats [29]. 
Consumption of a polyphenol rich grape extract prevented high fat diet-induced obesity 
by increasing in adiponectin secretion and reducing oxidative stress [30]. Additionally, 
our lab has shown that California table grape supplementation decreased insulin 
resistance acutely, and systemic inflammation chronically in mice fed an extremely high 
fat, lard-based diet (e.g., 60% kcals from lard;) [31].   
     Although the above studies indicate that plant polyphenols have beneficial health 
effects, these compounds have low bioavailability (i.e., less than 5% are absorbed in the 
upper intestinal tract, and thus the majority of ingested polyphenols reach the cecum and 
colon [reviewed in 11]. Therefore, we hypothesized that gut microbiota may be involved 
in mediating the beneficial systemic effects associated with grape consumption.   
 
Prebiotic Properties of Grapes 
     A prebiotic is defined as “the selective stimulation of growth and/or acitivity(ies) of 
one or a limited number of microbiota genus(era) species in the gut microbiota that 
confer(s) health benefits to the host” [32].  Grapes contain many components that have 
the potential to function as prebiotics.  For example, it has been demonstrated that 
feeding grape antioxidant dietary fiber, containing both the fiber and antioxidant 
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components from grapes, significantly increased Lactobacillus spp. within in the cecum 
of rats compared to controls [33]. Feeding broiler chicks a diet containing grape pomace 
or grape seed extract resulted in increases in ileal populations of Enterococcus spp., a 
beneficial bacterial species, while decreasing the concentrations of Clostridium spp., a 
pathogenic species [34].   
     It has been shown that certain fibers are metabolized by gut microbes and result in the 
production of short chain fatty acid (SCFA)s. This production of SCFAs, which includes 
butyrate, propionate, and acetate, has been associated with improvements in intestinal and 
systemic health.  For example, butyrate plays an integral role in the function and integrity 
of colonic cells. Colonic cells use butyrate as a preferred energy source and preferentially 
do so even in the presence of other substrates such as glutamine and glucose. Intestinal 
SCFA production also has the potential to inhibit the growth of pathogenic organisms 
through the mechanism of reducing the pH of both the lumen and feces. Additionally, 
butyrate has been shown to regulate gene expression, differentiation, and apoptosis of 
colonocytes and may provide a protective mechanism against colon carcinoma cells 
[reviewed in 35].  Through this specific inhibition of pathogenic organisms, the beneficial 
organisms residing in the colon are better able to thrive and may then be able to exert 
greater benefits.  Additionally, SCFAs have been associated with improvements in host 
metabolism [36].  For example, SCFAs produced via microbial fermentation has been 
demonstrated to activate the SCFA receptors GPR41 and 43 in WAT, which is associated 
with reduced fat accumulation.  Activation of these receptors also increases secretion of 
glucagon-like peptide 1 and 2 (GLP-1 and -2 resulting in increased insulin secretion and 
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sensitivity within muscle and liver [37].  Activation of GPR43 is also associated with 
reductions in inflammatory responses associated with consumption of a high fat diet [38].  
     In contrast to butyrate, acetate and propionate can increase energy harvest via 
increased absorption of these two SCFA.  For example, For example, propionate is a 
precursor for hepatic gluconeogenesis, propionate and acetate are precursors of 
cholesterol synthesis, and acetate and butyrate are substrates for hepatic and WAT 
triglyceride synthesis.  Average molar ratios of acetate, propionate, and butyrate are 60: 
23: 17 under normal feeding conditions.  However, these ratios can change greatly 
depending on diet composition, particular the due to the amounts and types of dietary 
fiber [38]. 
     While numerous research studies have shown that the prebiotic potential of certain 
foods to be highly dependent on the specific fiber content [reviewed in 35; reviewed in 
36], less is known about the capacity of the polyphenols in these same foods to elicit a 
prebiotic response. Because of this, recent research has focused on examining specific 
phenolic compounds in relationship to gut microbiota and colon health.  
     Studies that examine microbial metabolism of anthocyanins in the colon are scarce. 
However, research has shown that only a small fraction of dietary anthocyanins is 
absorbed in the upper intestinal tract, and therefore large amounts of these polyphenols 
are exposed to the microbial community in the cecum and colon, thereby impacting 
microbial growth and metabolism. [40]. The most abundant metabolites produced from 
anthocyanins include gallic acid and syringic acid, both of which have been shown to 
have antioxidant activities. Syringic acid has also been shown to inhibit cyclooxygenase 
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(COX-2), a enzyme catalyzing the conversion of arachidonic acid to prostanoids. Gallic 
and syringic acid have also been detected in large concentrations within the gut as well as 
the blood [41].  Collectively, these data indicate that anthocyanins and their metabolites 
may be responsible for some of the proposed health benefits associated with grape 
consumption.   
 
Summary of Published Data   
     Given the obesity epidemic, it is important to identify strategies to prevent and treat 
obesity.  The current literature indicates that genetic and diet-induced obesity is 
associated with chronic, low-grade inflammation systemically as well as within the gut 
[4-7].  Polyphenols, which are abundant in grapes, have been shown to have many anti-
inflammatory and anti-oxidant properties [8-11].  However, the mechanisms behind these 
actions are still unclear.  With diet-induced obesity, the populations of deleterious gram-
negative bacteria are more abundant than other beneficial bacterial species [13-16].  It has 
been suggested that these alterations in bacteria may play a role in initiating the 
inflammatory response within the gut, leading to the release of proinflammatory 
compounds (e.g., LPS) that enter the bloodstream and cause systemic health issues.  
Several research studies have shown that grape products or components increase 
beneficial microbial species within the gut such as Lactobacillus spp and Enterococcus 
spp [33, 34].  A polyphenol-rich extract from cranberries, similar in polyphenol 
composition to grapes, has been shown to increase the abundance of beneficial bacterium 
A. muciniphila resulting in improvements in the metabolic profile of obese mice [16].  
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Additionally, reductions in systemic markers of inflammation with feeding or 
supplementing grape products or their components have been observed [29].   Also, 
grapes contain many indigestible components such as anthocyanins and fiber that have 
been shown to reach the colon and subsequently be metabolized by the intestinal bacteria 
to yield beneficial metabolites such as gallic and syringic acid that possess antioxidant 
functions [40, 41].  These indigestible components may also impact SCFA production via 
bacterial fermentation which is associated changes in energy harvest and with activation 
of GPR41 and 43, depending on the type of SCFA produced, resulting in improvements 
in insulin sensitivity and host energy homeostasis [37, 38,39]. 
     Based on these data, I proposed the central hypothesis that California table grapes, and 
one or more of their bioactive fractions, would decrease adiposity, systemic 
inflammation, and insulin resistance associated with diet-induced obesity.  I predicted 
these beneficial systemic outcomes would be due, in part, to modulation of the gut 
microbiota and subsequent improvements in intestinal health. 
 
     To test my central hypothesis, the following specific aims were pursued:  
     Aim #1. Determine the extent to which California table grapes attenuate body fat 
accumulation, systemic inflammation, and insulin resistance, as well as impact gut 
microbiota in mice fed an American type diet rich in saturated fat from butter; and  
     Aim #2. Identify the key bioactive fractions in California table grapes responsible for 
reducing adiposity, inflammation, and insulin resistance, and modulating gut microbiota 
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in mice fed an American type diet rich in saturated fat from four sources.  These specific 
aims were be pursued in the following two chapters.
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Figure 2.1. Anti-Inflammatory and Anti-Oxidant Effects of Polyphenols in Obesity. 
Polyphenols have been shown to inhibit the production of pro-oxidant compounds 
including hydrogen peroxide (H202) reactive oxygen species (ROS), reactive nitrogen 
species (RNS), and nitric oxide (NO) thereby preventing activation of the MAPK, NFkB, 
and AP1 pathways and subsequent proinflammatory response.  Additionally, polyphenols 
have been shown to activate nuclear factor erythroid 2-related factor 2 (Nrf2), which 
increases the expression of antioxidant enzymes that inhibit oxidative damage and cell 
death associated with pro-oxidant compounds.  Polyphenols also may activate 
peroxisome proliferator-activated receptor gamma (PPARγ) and sirtuin 1 (Sirt1) which 
also inhibit NFκb and pro-inflammatory responses.  Sirt1 also can activate peroxisome 
proliferator-activated receptor γ coactivator 1 alpha (PGC1α) which stimulates beta-
oxidation and mitochondrial biogenesis, leading to glucose and fatty acid (FA) oxidation.   
Additionally, polyphenols may activate G-protein receptors (GPR) stimulating adenylate 
21 
 
cyclase (AC), cyclic adenosine monophosphate (cAMP), and 5’ adenosine 
monophosphate activated protein kinase (AMPK) which stimulate lipolysis, beta-
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CALIFORNIA TABLE GRAPE CONSUMPTION REDUCES ADIPOSITY, HEPATIC 
TRIGLYCERIDES, LIPOGENIC GENE EXPRESSION, AND ABUNDANCE OF 
SULFIDOGENIC BACTERIA IN MICE FED BUTTER FAT  
 
  
     Jessie Baldwin, Brian Collins, Patricia Wolf, Kristina Martinez, Wan Shen, Chia-Chi    
     Chuang, Wei Zhong, Paula Cooney, Chase Cockrell, H. Rex Gaskins, Eugene Chang,  





     The objective of this study was to examine the extent to which consuming polyphenol-
rich, California table grapes reduces adiposity, hepatic steatosis, markers of inflammation 
or lipid metabolism, or impacts gut microbiota in mice fed a butter-rich diet. Male, 
C57BL/6J mice were fed a low fat diet or butter-rich diet with or without 3% or 5% 
grapes for 11 weeks. Total body and inguinal fat content were reduced in mice fed both 
levels of grapes compared to their high-fat, sugar controls. Mice fed 5% grapes had lower 
liver weights and triglyceride levels, and decreased hepatic expression of lipogenic 
glycerol-3-phosphate acyltransferase (Gpat1) compared to 5% controls. Mice fed 3% 
grapes had lower hepatic mRNA levels of the lipogenic genes peroxisome proliferator-
activated receptor gamma 2, sterol-CoA desaturase 1, fatty-acid binding protein 4, and 
Gpat1 compared to 3% controls. In white adipose tissue (WAT), mice fed 5% grapes had
28 
 
decreased mRNA levels of the lipogenic gene acylglycerol-3-phosphate-O-
acyltransferase 2 compared to controls. Although grape feeding had only a minor impact 
on markers of inflammation in WAT or intestine, 3% grapes decreased the intestinal 
abundance of sulfidogenic Desulfobacter spp., and the Bilophila wadsworthia-specific 
dissimilatory sulfite reductase gene, and tended to increase the abundance of the 
beneficial bacterium Akkermansia muciniphilia compared to controls. In addition, via 16s 
rRNA sequencing of cecum mucosa, Bifidobacterium, Lactobacillus, Allobaculum, and 
other genera were found to be negatively correlated with body fat percentage and 
inguinal fat weight. Allobaculum in particular was increased in both the LF and 3% 
grapes groups.  Notably, grape feeding attenuated the high-fat induced impairment in 
localization of the intestinal tight junction protein zonula occludens. Collectively, these 
data indicate that some of the adverse health consequences of consuming a diet rich in 
saturated fat can be attenuated by table grape consumption. 
 
Introduction  
     Currently 35.9% of adults and 17% of youth in the United States have been diagnosed 
as obese [1]. Obesity is also a global health condition affecting more than 10% of adults 
worldwide [2]. Of growing concern is the association between the rise in obesity and 
chronic inflammatory conditions such as type 2 diabetes, hypertension, and 
cardiovascular disease [3].  Physiologically, obesity is the result of an expansion of white 
adipose tissue (WAT) which typically elicits inflammatory signals involved in the 
recruitment of macrophages and other immune cells into the WAT. This results in a 
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proliferation of circulating and tissue levels of proinflammatory cytokines and 
chemokines [4]. While increased tissue levels of these proinflammatory agents 
perpetuates the inflammatory cycle, those released systemically impair glucose disposal 
and lipid metabolism and hemostasis that contribute to the development of metabolic 
diseases. However, the exact mechanisms which initiate WAT inflammation resulting 
from diet-induced obesity remain unclear.     
     Gut microbes have received much attention due to their potential involvement in the 
development of obesity [5], chronic inflammation [6-8], and insulin resistance [9]. Diets 
high in fat, particularly those rich in saturated fatty acids  found in milk fat [10], have 
been implicated in the reduction of gut barrier-protecting bacteria as well as increasing 
the abundance of deleterious bacteria including sulfidogenic bacteria [reviewed in 11]. A 
correlation exists between the extent of these changes in microbiota and the degree of 
obesity and insulin resistance in test subjects [12]. Furthermore, the main byproduct of 
sulfidogenic bacteria like Bilophila wadsworthia and Desulfovibrionaceae spp. is 
hydrogen sulfide gas, which is genotoxic and cytotoxic and positively correlated with 
development of ulcerative colitis, gut inflammation, irritable bowel syndrome, and colon 
cancer [10, 13, 14].   
     In contrast, changes to the intestinal microbiome can have beneficial effects. Indeed, 
research models have demonstrated that elimination of gut microbes [5-9, 11, 12, 15] or 
inoculation with specific pre- (e.g., non-digestible sugars, fiber, or polyphenols) or 
probiotics (e.g., Lactobacillus acidophilus, Bifidobacterium spp., Akkermansia 
muciniphila, Clostridium trybutyricum) [reviewed in 11, 16-19] can attenuate obesity or 
30 
 
metabolic dysfunction. Polyphenols found in fruits and vegetables [20-22] are of 
particular interest as they are poorly absorbed in the upper gastrointestinal tract, and thus 
persist in the distal small intestine, cecum, and colon [23] where they may influence 
microbiota taxa and their metabolites [24]. In addition, their anti-inflammatory, anti-
oxidant, or anti-microbial actions have been reported to positively influence gut microbes 
and inflammation [reviewed in 25].  
     Grapes are rich in polyphenols including anthocyanins [reviewed in 25], and thus may 
have beneficial effects on intestinal or systemic inflammation. The anti-inflammatory and 
anti-oxidant properties of California table grapes have been demonstrated in rats 
supplemented with 9 human servings (3%, w/w) of powdered table grapes for 18 weeks, 
resulting in lowered blood pressure, improved cardiac function, and reduced systemic 
inflammation and oxidative damage [26]. These effects correlated with increased cardiac 
peroxisome proliferator-activated receptor (PPAR)α/γ activity and decreased nuclear 
factor kappa B (NF-κB) activity, along with reductions in cytokine levels [27]. Similarly, 
table grape-mediated reductions in atherosclerotic lesion areas were associated with 
increased serum antioxidant status and decreased macrophage-mediated oxidation of low 
density lipoproteins (LDL) [28]. Additionally, when women supplemented with 
powdered California table grapes (36 g/d) their plasma lipid profile improved and plasma 
(e.g., tumor necrosis factor alpha, TNFα) or urine (e.g., prostaglandin F2 alpha) markers 
of inflammation and oxidative stress were reduced [29]. Consistent with these data, we 
demonstrated that C57BL/6J mice fed a high fat diet (60% kcals from lard) supplemented 
with powdered California table grapes (3%, w/w), improved glucose tolerance at 5 
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weeks, and decreased markers of inflammation ≈20-50% in serum and WAT at 18 weeks 
without affecting body fat levels or food intake [30].  
     Collectively, these data indicate that; (i) gut microbiota are influenced by diets 
abundant in saturated fats such as butter fat, in a manner that impacts gut inflammation 
and barrier function, and systemic inflammation, (ii) non-digestible carbohydrates and 
polyphenols positively impact adverse outcomes caused by high fat-feeding, and (iii) 
grape consumption can attenuate inflammation and oxidative stress in several animal 
models and in humans. However, little is known about how California table grapes 
decrease chronic inflammation associated with saturated fat-feeding and obesity. 
Therefore, the objective of this study was to examine the extent to which consuming 
California table grapes reduces adiposity, hepatic steatosis, markers of inflammation or 
lipid metabolism, or impacts gut microbiota in mice fed a butter-rich diet. 
 
Materials and Methods  
Animals 
     Four-week old, male C57BL/6J mice were obtained from Jackson Laboratories (Bar 
Harbor, ME, USA) and acclimated on a standard chow diet for 1 week. Mice were 
housed in pairs, maintained at a temperature of 22◦C with 50% humidity, and exposed to 
a 12 h light/ 12 h dark cycle. Mice received food and water ad libitum and measures of 
body weight and food intake were conducted once and twice per week, respectively. All 
experimental procedures were performed under ethical standards and approved by the 
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     Animals were randomly assigned to one of five dietary treatments (n=10 per treatment 
group) as follows: low fat (LF; 10% of energy from  fat), high fat (HF; 34% of energy 
from fat) plus 3% powdered grapes (w/w; HF-3G), high fat plus 3% sugar (w/w; HF-3S), 
high fat plus 5% powdered grapes (HF-5G) and high fat plus 5% sugar (HF-5S). The high 
fat diets consisted of approximately 3% energy from soybean oil and 31% energy from 
butter. Thus, the HF diets were rich in fat, especially saturated fat, and mimicked the 
average calories from fat in an American-type diet. The lyophilized (i.e., powdered) 
California table grapes, kindly provided by the California Table Grape Commission 
consisted of a mixture of red, green, and purple seeded and seedless grapes.  The 3% and 
5% dietary levels of grapes were comparable to 9 and 15 human servings (1 serving is 
equivalent to 1 cup of whole berries) of grapes, respectively. The HF-3S and HF-5S diets 
consisted of a mixture of fructose and glucose to control for the natural sugar content of 
the powdered grape diets. Detailed composition of the diets is illustrated in Table 3.1.  
 
Intraperitoneal glucose tolerance tests (GTT) and fasting insulin levels  
     Intraperitoneal (i.p.) GTT were performed on weeks 3, 6, and 9 on non-anesthetized 
mice. Mice were fasted for 8 h and given an i.p. injection of glucose (i.e., 20% solution at 
1 g/kg body weight). Blood from the tail vein collected at baseline and 5, 15, 30, 60, and 
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120 minutes post-i.p. glucose injection was used to quantify glucose levels using a Bayer 
Contour blood glucose monitor and strips (Bayer Healthcare, Tarrytown, NY, USA). 
Plasma insulin levels were detected using an ultrasensitive mouse insulin kit (Crystal 
Chem, Inc, Downers Grove, IL). The homeostasis model assessment method (HOMA) 
for insulin resistance (IR) was used employing the following formula: [fasting insulin 
concentration (ng/ml) x 24 x fasting glucose concentration (mg/dl)] / 405 [16]. 
 
Body fat measurements via Dual X-Ray Absorptiometry (DEXA) 
     Percent body fat was measured using DEXA on a GE Lunar Prodigy Advanced 
System (GE Healthcare, Milwaukee, WI) at weeks 5 and 10. During the measurement, 
mice were lightly anesthetized with isoflurane using a SomnoSuite Small Animal 
Anesthesia System with Integrated Digital Vaporizer isoflurane system. Measurements 
were taken in duplicate to reduce the possibility of error and values expressed are an 
average of the two measurements.  
 
Tissue collection 
     After 11 weeks of dietary intervention, mice were fasted for 8 h and euthanized via 
isoflurane-induced anesthesia followed by decapitation. Plasma was collected at time of 
harvest. Four white adipose tissue (WAT) depots were collected; epididymal, mesenteric, 
inguinal, and retroperitoneal. Additionally, livers were harvested and intestinal mucosa 
and digesta were collected from the duodenum, jejunum, ileum, cecum, and proximal and 
distal colon. Weights of the WAT depots and liver were recorded and all collected 
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samples were immediately snap-frozen in liquid nitrogen and stored at -80oC until 
analysis.  
 
Liver and serum triglyceride (TG) levels 
 Liver TG content was measured as previously described [31]. Plasma TG content was 
determined using a commercial assay from Thermo Scientific and was conducted 
following the manufacturer’s protocol (Infinity TG assay #TR22421 and TG standards 
#TG22923; Norcross, GA). 
 
RNA extraction and qPCR 
     Adipose and intestinal samples were homogenized in QIAsol reagent and total RNA 
was extracted using QIAgen mini lipid kit obtained from Qiagen (Valencia, CA). For 
hepatic samples, a QIAgen mini universal kit from Qiagen was used. The quality and 
concentration of RNA were examined using absorbance at 260 nm and integrity 
determined using the absorbance ratio of 260/280 on a Nanodrop ND-1000 
Spectrophotometer (Thermo Scientific, Wilmington, DE). Complementary DNA was 
created by reverse transcription using 1 ug of RNA and a high capacity cDNA Archive 
Kit (Applied Biosystems, Foster City, CA) according to manufacturer’s protocols. qPCR 
was performed in a 7500 FAST Real Time PCR system (Applied Biosystems). The 
expression of different genes related to inflammation, lipogenesis, and lipolysis in WAT 
depots and liver were measured using Taqman Gene expression assays purchased from 
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Applied Biosystems. TATA-binding protein (Tbp) was the endogenous reference gene 
utilized for all assays and fold differences in gene expression were calculated as 2−ΔΔCt. 
 
Immunoblotting 
     Immunoblotting was conducted as previously described [31] using primary antibodies 
for sterol-CoA desaturase-1 (#2283S; SCD1, Cell Signaling), carnitine 
palmitoyltransferase 1A (#12252S; CPT1a, Cell Signaling), peroxisome proliferator-
activated receptor gamma (#2443S; PPARγ Cell Signaling), β-actin (#4967; Cell 
Signaling), proliferator-activated receptor alpha (#sc9000; PPARα, Santa Cruz 
Biotechnology Inc., Santa Cruz, CA), glycerol-3-phosphate acyltransferase (#sc382257; 
GPAM, Santa Cruz), and sterol regulatory element-binding protein 1C (#sc366; 
SREBP1c, Santa Cruz) all at dilutions of 1:1000. Adipocyte fatty acid binding protein 
(aP2) was kindly provided by Dr. David Bernlohr (U. of Minnesota) and used at a 
1:10,000 dilution. Horseradish peroxidase-conjugated secondary antibodies were probed 
for 2 h at room temperate at 1:1000 dilutions. Blots were exposed to a 
chemiluminescence reagent and X-ray films were developed using a SRX-101A Konica 
Minolta film developer.    
 
Barrier function in ileum 
     The localization of the tight junction protein zonula occludens-1 (ZO-1) was 
determined in ileum samples that had been embedded in Tissue-Tek Cyro-OCT 
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compound, sliced in 5 mm sections, fixed in cold methanol, and incubated with a 
polyclonal rabbit anti-ZO-1 antibody as previously described [32]. 
 
PCR amplification of 16S rRNA and functional gene targets  
    Real-time quantitative PCR (qPCR) was performed with a 7900HT Fast Real-Time 
PCR System (Applied Biosystems, Foster City, CA). 16S rRNA gene-specific primers 
were used to target specific bacterial genera; Akkermansia muciniphila, Bilophila  
wadsworthia (F-AAGTCCTTCGGGGCGAGTAA) (R-ATCCTCTCAGACCGGCTAC), 
Desulfovibrio spp. (DSV), Desulfobulbus spp. (DBB), Desulfobacter spp. (DSB), and 
Desulfotomaculum spp. (DFM) [4]. The B. wadsworthia-specific dissimilatory sulfite 
reductase (dsrA-Bw) [20], which encodes an enzyme that catalyzes a step in the reduction 
of inorganic sulfate to hydrogen sulfide, was targeted to measure the abundance of this 
member of the Desulfovibrionaceae family.   Four functional genes utilized by 
Fusobacterium nucleatum in the fermentation of cysteine were measured; i.e., two 
homologues of L-cysteine desulfhydrase (FN0625 and FN1220), Cystathionine-β 
synthase (FN1055), and L-methionine-γ-lyase (FN1419). The abundance of butyrate-
producing bacteria was also measured using the degenerate primer Butyrl-CoA 
transferase.  Standard curves were constructed using cloned 16S rRNA and functional 
genes or amplified PCR product. Genomic DNA extraction and PCR experiments were 





 Sequencing of 16s rRNA gene using Illumina Mi-Seq platform  
     To assess bacterial community structure, primers specific for 16S rRNA V4-V5 region 
(Forward: 338F: 5’-GTGCCAGCMGCCGCGGTAA-3’ and Reverse: 806R: 5’- 
GGACTACHVGGGTWTCTAAT-3’) that contained Illumina 3' adapter sequences as 
well as a 12-bp barcode were used. Sequences were generated by an Illumina MiSeq 
DNA platform at Argonne National Laboratory and analyzed by the program 
Quantitative Insights Into Microbial Ecology (QIIME) [33]. Operational Taxonomic 
Units (OTUs) were picked at 97% sequence identity using open reference OTU picking 
against the Greengenes database (05/13 release) [34]. OTUs were quality filtered based 
on default parameters set in the open-reference OTU command in QIIME and sequences 
were rarified to an equal sampling depth of 15000 reads per sample. Representative 
sequences were aligned via PyNAST [33], taxonomy assigned using the RDP Classifier 
[35], and a phylogenetic tree was built using FastTree [36]. Beta Diversity is represented 
by measuring UniFrac distances calculated using both weighted and unweighted 
algorithms and visualized with PCoA plots generated in Emperor. Prior to statistical 
analyses, OTUs occurring in less than 50% of samples were filtered from the OTU table. 
Significant changes in OTU abundance were assessed using Kruskal Wallis test (FDR 
correction p ≤ 0.05). Multivariate statistical tests include ADONIS, ANOSIM, and 
PERMANOVA tests [33]. Spearman correlations and Principal Component Analysis 






     Data were analyzed using a one-way ANOVA and Student’s t test to compute 
individual pairwise comparisons of means (p<0.05). We also used Bonferroni’s posthoc 
test to perform specific comparisons where appropriate. Analyses were conducted using 
the JMP software program version 10.0 for Windows (SAS, Cary, NC).  Relative 
abundances generated from 16s rRNA sequencing were analyzed in GraphPad Prism 
Version 6 using ANOVA followed by Dunn’s test for multiple comparisons. Data are 
expressed as means + S.E.M. 
 
Results 
Grape consumption decreases body fat  
     Body weight gains and energy intakes were greater in all HF-fed mice compared to 
the LF control mice (Table 3.2). Mice fed powdered grapes (HF-3G, HF-5G) had similar 
body weights and energy intakes compared to their HF-sugar controls (HF-3S, HF-5S; 
Table 3.2). Mice fed the HF-sugar control diets had greater body fat percentage and total 
WAT depot weights compared to the LF controls (Fig. 3.1). Mice fed the HF-3G diet had 
lower percent body fat at week 5 and mice fed powdered grapes at both levels had lower 
body fat percentages and inguinal fat depot weights at week 10 compared to their 
respective HF-sugar controls (Fig. 3.1). The HF-3G diet had lower total WAT depot 





GTT, fasting glucose, insulin, and TG levels, and HOMA-IR scores unaffected by grapes 
     To assess the impact of grape consumption on insulin resistance and glucose 
sensitivity, GTT were conducted at weeks 3, 6, and 10, and fasting plasma glucose and 
insulin and HOMA-IR were measured at week 11. Mice consuming the HF-sugar control 
diets had impaired GTT at all three time points compared to the LF controls (Fig. 3.2). 
However, consuming grapes did not significantly improve GTT, fasting insulin, glucose, 
serum TG levels, or HOMA-IR scores. 
 
Grape consumption lowers hepatic TG levels and the expression of several lipogenic 
genes  
     Liver tissue was analyzed to assess the impact of grape consumption on liver TG 
levels and markers of lipogenesis and fatty acid oxidation. Mice consuming the HF-sugar 
control diets had greater liver weights, TG levels (HF-5S only), and mRNA levels of the 
lipogenic genes Pparγ2, Scd1 (HF-5S only), Srebp1c, cluster of differentiation 36 (Cd36; 
HF-5S only), and glycerol-3-phosphate acyltransferase 2 (Gpat2; HF-3S only) compared 
to the LF-fed mice (Fig. 3.3). Mice fed the HF-3G diet had decreased mRNA levels of 
Pparγ2, Scd1, fatty acid binding protein 4 (Fabp4), and Gpat1 compared to the HF-3S 
controls. Mice fed the HF-5G diet had decreased TG levels and mRNA levels of Gpat1 
compared to the HF-5S controls. None of the genes associated with fatty acid oxidation 
(e.g., Pparα, Cpt1a, acyl-CoA oxidase 1 (Acox1)) were impacted by grape feeding. 
Consuming grapes had no impact on the protein levels of Pparγ, Scd1, Pparα, Fabp, 
Cpt1a, or Gpam (data not shown). 
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Grape consumption differentially impacts WAT genes associated with inflammation and 
lipid metabolism 
     To determine whether insulin resistance caused by HF-feeding was due to WAT 
inflammation, inguinal (subcutaneous), epididymal (visceral), and mesenteric (visceral) 
WAT mRNA levels for several proinflammatory genes (i.e., cluster of differentiation 11c 
(Cd11c), epidermal growth factor-like module containing mucin-like hormone receptor 1 
(Erm1; F4/80 human orthologue), monocyte chemoattractant protein 1 (Mcp1),  Tnfα, 
Toll-like receptor 4 (Tlr4), and interleukin 6 (Il6) were measured. In epididymal WAT, 
mice fed the HF-sugar controls had increased mRNA levels of Tnfα (HF-5S), Cd11c (HF-
5S), Il6, and Mcp1 (HF-5S) compared to the LF controls (Fig. 3.4A). Grape feeding had 
no impact on these genes.  In inguinal depot WAT, only mice fed the HF-5S diet had 
increased inflammatory gene expression (i.e., Mcp1), which was decreased in mice fed 
the HF-5G diet (Fig. 3.4A). In mesenteric WAT, inflammatory gene expression was not 
increased by HF-feeding. 
     To determine if the reduction in adiposity by grape consumption was due to alterations 
in the expression of genes associated with fat synthesis or oxidation, epididymal and 
inguinal WAT were analyzed for mRNA markers of; (i) lipogenesis (i.e., Pparγ2, 
Srebp1c, Scd1, acylglycerol-3-phosphate-O-acyltransferase 2 (Agpat2), fatty acid 
synthase (Fas), acetyl-CoA carboxylase (Acc), perilipin 1 (Plin1), Gpat1), (ii) lipolysis 
(i.e., adipose TG lipase (Atgl); and (iii) beta-oxidation (i.e., Acox1, Cpt1b, Pparα). In 
epididymal WAT, the mRNA levels of the lipogenic genes Pparγ2, Agpat2, and Scd1 
(HF-5S) were higher in the HF-sugar controls compared to the LF-controls, and similar to 
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the HF-grape groups (Fig. 3.4B).  In inguinal WAT, the mRNA levels of the lipogenic 
genes Srebp1c (HF-3S), Scd1, Agpat2 (HF-5S), Fas (HF-5S), and Gpat2 (HF-5S) were 
higher in the HF-sugar controls compared to the LF-controls (Fig. 3.4C). Mice fed the 
HF-5G diets had lower mRNA levels of Agpat2 compared to HF-5S control.  The mRNA 
levels of the fatty-acid oxidizing genes Pparα and Cpt1b, and the lipolytic gene Atgl (HF-
3S) were lower in the HF-sugar controls compared to the LF control, and similar to the 
HF-grape groups. 
 
Minimal influence of HF-feeding and grape consumption on markers of intestinal 
inflammation and barrier function 
     Given the reported adverse effects of consuming saturated fats [reviewed in 11], 
particularly from milk fat [10], on intestinal health, and potential prebiotic impact of 
grapes, we measured the effects of our diets on markers of intestinal inflammation and 
barrier function. For inflammatory status, the mRNA levels of Cd11c, Erm1, Mcp1, Tnfα, 
Tlr4, and Il6 in ileum and distal colon mucosa and the activity of duodenal alkaline 
phosphatase and ileal myeloperoxidase were measured. Surprisingly, the only 
proinflammatory gene increased in the ileal mucosa of HF-sugar fed mice was Tnfα, 
which was similar to the HF-5G group (Fig. 3.5A). None of the proinflammatory genes 
measured in the colonic mucosa where increased by HF-sugar feeding or grape 
consumption. Similarly, the activities of alkaline phosphatase and myeloperoxidase were 
not influenced by HF-sugar feeding or grape consumption (data not shown).   
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     To assess intestinal barrier function, the mRNA levels of the tight junction proteins 
zonula occludens (Zo1), claudin-1, and occludin-1 and the localization of ZO-1 at the 
apical surface of the ileal epithelium were measured. Although the ileum mucosal gene 
expression of these tight junction proteins was not impacted by the diets, the localization 
of ZO-1 was impaired in the HF-sugar control diets compared to the LF controls, and 
improved by grape feeding (Fig. 3.5B).  
 
16s rRNA sequencing of the gut microbiota reveals genera associated with body fat 
percentage and inguinal fat pad weight  
     Given the reported adverse effects of consuming saturated fats [reviewed in 11], 
particularly from milk fat [10], on intestinal microbes, we measured the effects of our 
diets on the abundance of several mucosal sulfidogenic bacteria (i.e., DBB, DSB, dsrA, 
DFM, DSV, and B. wadsworthia) or their gene products (i.e., B. wadsworthia specific 
dsrA-Bw, Fusobacterium nucleatum functional genes including two L-cysteine 
desulfyhdrases (FN0625 and FN1220) cystathionine-β synthase (FN1055), and L-
methionine-γ-lyase (FN1419)). Although HF-feeding did not increase the expression of 
any of these genes associated with sulfur metabolism in ileum or colon mucosa compared 
to LF control mice (data not shown), mice consuming the HF-3G diet had decreased 
mRNA levels of DSB and dsrA-Bw expression in ileum mucosa compared to mice 
consuming the HF-3S diet (Fig. 3.6A).  
     We also measured the expression of a functional gene (i.e., butyrl-CoA transferase) of 
health- promoting, butyrate-producing bacteria and on the abundance of Akkermansia 
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muciniphila, a mucin-degrading bacteria associated with prebiotic-mediated reduction in 
obesity [37]. Although not statistically significant, mice consuming grapes had increased 
levels of Akkermansia muciniphila in the cecum digesta (HF-3G), colon digesta (HF-3G), 
and proximal colon mucosa (HF-5G) compared to their HF-sugar controls (Fig. 3.6B). 
 
 Sequencing of the 16s rRNA gene reveals alterations in microbial structure and 
relationships    
     In order to better understand the impact of grape feeding on gut bacterial community 
structure, an untargeted approach was used by sequencing the 16s rRNA gene in cecum 
mucosal samples. Sequencing was performed on an Illumina MiSeq platform using 
primers targeting the V4-V5 region of the 16s rRNA gene. Data were analyzed using 
QIIME 1.8 Software (33-Caporaso et al. 2010). Alpha Diversity analyses revealed that 
the HF groups containing 5% grapes or 5% sugar resulted in reduced observed species 
compared to 3% grapes (p = 0.0002) or 3% sugar (p< 0.0001), respectively (Fig 3.7). 
Notably, HF diet containing 3% sugar reduced observed species compared to 3% grapes 
(p=0.0026), but there was no difference in observed species in 5% grape and sugar 
groups. These results suggest that elevated sugar content may result in decreased alpha 
diversity or membership of the gut microbiota.  Principal Coordinate Analysis (PCoA) of 
weighted UniFrac distances did not reveal obvious differences in beta diversity or 
community structure across diet groups but there was clear separation between the LF 
group and HF groups based on unweighted UniFrac distances (Fig. 3.8). To further 
interrogate differences between diet groups, multivariate statistical tests including 
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ADONIS, ANOSIM, and PERMANOVA were conducted. Significant differences were 
found among both unweighted and weighted UniFrac distances across diet groups (Table 
3.3). Subsequently, OTUs that were not represented in up to 50% of the samples were 
removed to reduce noise from low abundance OTUs. Next, a Kruskal Wallis test was 
performed to determine significant differences in relative abundance of taxa between 
groups. Here, it was found that several bacterial taxa were significantly altered based on 
diet (Fig. 3.9). While many genera were reduced in the HF diets compared to the LF diet, 
some were selectively increased in HF-3G group such as Ruminoccocus and 
Anaeroplasma in the Firmicutes and Tenericutes phylum, respectively (Fig. 3.9).  
     To assess differences between specific diet groups, Principal Component Analysis 
(PCA) was conducted and clear clustering was evident between the LF and HF-3G group 
(Fig. 3.10A) and between the HF-3G and HF-3S group (Fig 3.10B). Principal 
Component Analysis between the LF and HF-3G group revealed that ~60% of the 
variance in relative bacterial abundance between the two groups is explained with 
Principal Component 1 (PC1).  PC1 exhibits strong correlations with two strains of 
bacteria: S24-7 within the Bacteroides phylum and Clostridiales in the Firmicutes 
phylum (Fig. 3.10A).  This indicates that the variance explained by PC1 is primarily due 
to the relative abundances of these two bacterial strains.  Principal component 2 (PC2) 
explained an additional 20% of the variance between groups and was primarily correlated 
with Akkermansia.  PCA between the HF-3G and HF-3S groups revealed that ~60% of 
the variance in relative microbial abundance between the two groups was explained by 
PC1.  PC1 was once again strongly correlated with S24-7 and Clostridiales (Fig. 
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3.10B).  PC2 explained ~20% of the variance and exhibited a strong correlation with 
Akkermansia, however this was positively associated with the HF-3S group. These data 
suggest that most variance between the LF and HF-3G was explained by the abundance 
of S24-7 in the LF group. Interestingly, S24-7 also explained the variance between the 
HF-3G and HF-3S groups, as it was positively correlated with HF-3G compared to HF-
3S. These data may suggest that S24-7 is associated with improved metabolic profile of 
the LF and HF-3G groups. 
     Lastly, Spearman Correlation analysis revealed significant negative correlations 
between body fat percentage and several genera (Fig. 3.11, Table 3.4) with the most 
profound being Bifidobacterium (p = 0.0001), a butyrate producer, and others including 
Lactobacillus (p = 0.0221) and Allobaculum (p = 0.034; Fig 3.11, Table 3.4). These 
particular genera were similarly correlated with inguinal fat pad weight. Clostridiales of 
the Firmicutes phylum was positively correlated with body fat percentage (p = 0.0065). 
Interestingly, a heatmap made from the taxa that were significantly correlated with body 
fat percentage, reveals that Allobaculum belonging to the Tenericutes phylum was 
increased in both the LF and HF3G group (Fig. 3.11). Little is known regarding the 
functional role of Allobaculum in the gut ecosystem and is currently being investigated 
for its potential association with a lean phenotype and improved metabolic health.  
 
Discussion 
     Our data demonstrate that consuming table grapes (i.e., 3-5%, w/w; equivalent to 9-15 
human servings) attenuates the accumulation of body and liver fat in mice fed a diet rich 
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in butter compared to control mice. However, these lipid-lowering effects of grapes were 
not associated with improvements in glucose tolerance or markers of inflammation in 
intestinal mucosa or WAT. Notably, the impaired localization of the intestinal tight 
junction protein ZO-1 in high fat-fed mice was improved by grape consumption. 
Populations of the deleterious sulfidogenic bacteria Desulfobacter spp, and the Bilophila 
wadsworthia-specific dissimilatory sulfite reductase gene were decreased by grape 
consumption (HF-3G), and populations of the beneficial bacterium Akkermansia 
muciniphila tended to be higher the colonic mucosa (HF-5G) or digesta (HF-3G) of grape 
fed mice compared to their respective controls. Additionally, via 16s rRNA sequencing 
analysis, we found significant differences across groups in the relative abundance of S24-
7 and Akkermansia which were found to be negatively correlated with HF diet compared 
to the LF diet. Intriguingly, correlation analysis showed a strong negative correlation 
between Bifidobacterium and body fat percentage and inguinal fat pad weight. Taken 
together, these data indicate that consumption of table grapes attenuates adiposity and 
steatosis that are positively correlated with a marker of intestinal integrity and changes in 
several species of gut microbes in mice fed a butter-rich diet.   
 
Influence of dietary polyphenols on adiposity, steatosis, and glucose tolerance 
     Many studies have demonstrated that consuming diets rich in calories from fat, 
particularly saturated fat, and sugars promote obesity and its metabolic complications 
[reviewed in 11].  The ability for foods rich in polyphenols, including grapes, to prevent 
obesity-mediated inflammation or related disorders has been demonstrated [reviewed in 
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25]. For example, grape seed procyanidin extract supplementation reduces body weight 
gain and adipose tissue mass in hamsters fed a HF diet [38].  Additionally, mice fed a HF 
diet supplemented with muscadine grape phytochemicals rich in anthocyanins had 
decreased body weights, less lipid accumulation in the liver, and improved glucose 
tolerance compared to high fat controls [39]. 
     While several studies demonstrate anti-inflammatory and anti-obesity effects of grapes 
or their extracts, the mechanisms by which these effects occur are less clear.  
Anthocyanins are one of the most abundant phytochemicals in grapes [30] and therefore 
may be responsible for mediating the reductions in adiposity and steatosis. For example, 
anthocyanins purified from purple sweet potatoes attenuated hepatic lipid accumulation 
via the activation of adenosine monophosphate-activated protein kinase and decreased 
expression of SREBP1 and its downstream target genes in mice fed a HF diet [40].  Our 
study found that powdered grape supplementation at 3% and 5% reduced body weight 
and fat gain and hepatic lipid accumulation, but  had no significant effects on the 
expression of Srebp1c and Fas.  One explanation for the differential effects of extracted 
anthocyanins cited above [40] and our anthocyanin-rich grapes may be due to the binding 
of anthocyanins to fibers or proteins in the intact grapes, making them less bioavailable to 
the host. Although we discovered that the expression of several hepatic genes associated 
with lipogenesis (e.g., Pparγ, Scd1, Fabp4, Gpat1) in liver were lower in mice 
consuming the HF-3G compared to the HF-3S controls,  the protein levels of associated 
with these genes were not lowered by grape feeding. However, we did not measure the 
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activity of these proteins, and therefore do not know they were impacted by grape 
consumption. 
 
Relationship between dietary fat, sulfite-reducing bacteria, barrier function, and 
inflammation  
     Devkota et al. [10] demonstrated that feeding a milk-fat-based diet similar in amount 
and composition to the western diet (i.e., 37% kcals from fat) to IL-10 knockout mice 
decreased gut barrier-protecting bacteria and increased sulfate-reducing bacteria and 
increased intestinal markers of inflammation consistent with inflammatory bowel disease 
[10]. Mice consuming the milk fat diet had increased abundance of B. wadsworthia, 
which was associated with a pro-inflammatory T helper type immune response and 
increased colitis. Notably, taurine-conjugated bile salts caused these inflammatory 
responses, in part, due to their high sulfur content, which stimulates sulfite-reducing 
bacteria like B. wadsworthia. In a parallel 3 week study, these authors fed C57BL/6J 
mice the same high fat diet [10]. Consistent with the IL-10 knockout mice, C57BL/6J 
mice fed the milk fat diet had an increased bloom of the sulfidogenic bacteria B. 
wadsworthia and the B. wadsworthia-specific dissimilatory sulfite reductase gene dsrA-
Bw. Milk fat-fed C57/6J mice also had a higher abundance of Bacteriodetes and a lower 
abundance of Firmicutes compared to the low fat-fed mice [10]. However, milk fat-fed 
C57BL/6J mice did not present overt colitis as did the IL-10 knockout mice [10]. In the 
present study, we did not observe any increases in the expression of sulfidogenic 
bacteria-related genes in the high fat-fed controls compared to the LF fed mice, although 
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the HF-3G had lower expression levels of dsrA-Bw and DSB in the ileum mucosa 
compared to the HF-3S control group (Fig. 3.6A). This decreased abundance of 
sulfidogenic bacteria correlated with improved localization of the ileal tight junction 
protein ZO-1 (Fig. 3.5). Although no markers of inflammation in the intestinal samples 
were significantly increased by the milk fat based diet or decreased by grape feeding, the 
expression levels of several inflammatory genes in visceral epididymal WAT (i.e., Tnfα, 
Cd11c, Mcp1) and subcutaneous inguinal WAT (i.e., Mcp1) were increased by HF 
feeding (Fig. 3.4A), and HF-5G consumption reduced Mcp1expression in inguinal WAT 
compared to its control HF-5S (Fig. 3.4A).   
     These results are comparable to data showing that HF feeding selectively increases the 
abundance of a specific type of bacteria that are associated with intestinal inflammation 
[41]. Apoa-I knockout mice, which present impaired glucose tolerance and increased 
adiposity, and wild type mice were fed a very HF diet (i.e., ~60% kcals from lard) for 25 
weeks. HF fed mice had increased abundance of Desulfovibrionaceae, a family of 
sulfate/sulfite reducing bacteria that produce hydrogen sulfide, a genotoxic gas that 
causes barrier dysfunction and endotoxemia [42].  Consistent with these data, we showed 
that C57BL/6J mice fed a very HF diet (i.e., ~60% kcals from lard) for 20 weeks 
increased three types of sulfidogenic bacteria in colonic mucosa, impaired localization of 
ZO-1, and mRNA levels of markers of macrophage infiltration in intestinal mucosa and 
WAT compared to LF fed mice [32]. Collectively, these data demonstrate that consuming 
diets enriched with lard or butter, two fat sources containing high levels of saturated fatty 
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acids, increases the abundance or markers of sulfate-reducing bacteria associated with 
impairment of intestinal barrier function and contribute to systemic inflammation. 
 
Relationship between dietary fat, Akkermansia muciniphila, barrier function, and 
inflammation 
     Akkermansia muciniphila, a commensal, mucin-degrading bacteria, plays a role in 
preventing the development of diet-induced obesity [37]. Under normal conditions, these 
bacteria represent 3-5% of the gut microbial population in humans. However, HF feeding 
reduces the colonic abundance of these bacteria in mice 100-fold, and oligofructose 
prebiotic treatment prevents this loss. Oligofructose-mediated increase in A. muciniphila 
was linked to decreased metabolic endotoxemia and markers of inflammation in WAT. 
Furthermore, supplementation of C57BL/6J mice fed a HF diet with A. muciniphila for 4 
weeks lead to a decrease in adiposity, gut barrier dysfunction, metabolic endotoxemia, 
glucose intolerance, insulin resistance, and Cd11c expression in WAT, and improved 
mucus thickness along the epithelium compared to control mice [37]. Consistent with 
these data demonstrating that oligofructose prebiotic treatment attenuates a HF diet-
induced reduction of A. muciniphila, our data indicate that supplementing high fat, butter-
rich diets with 5% California table grapes increases the abundance of A. muciniphila in 
proximal colon mucosa compared to the HF-sugar controls (Fig. 3.6B). This increase in 
A. muciniphila was positively associated with improved localization of ZO-1 in the apical 
area of the ileal epithelium compared to HF control mice (Fig. 3.5). Furthermore, based 
on our 16s rRNA sequencing data of the cecum mucosa, the genus Akkermansia was 
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positively associated with mice fed a LF diet, further supporting a relationship with a lean 
phenotype.  
 
Limitations and unanswered questions 
     The current study did not achieve the anticipated increases in intestinal and systemic 
inflammation in young C57Bl/6J mice fed a high fat diet rich in milk-fat as demonstrated 
in IL-10 knockout mice fed milk-fat [10] or in Apoa-I knockout mice fed lard [41].  
Perhaps feeding mice extremely HF diets (e.g., 60% kcals from lard) is necessary to 
instigate intestinal and systemic inflammation [11, 30]. Our current study sought to 
provide a more physiological approach to achieve diet-induced obesity accompanied by 
systemic and intestinal inflammation. The use of this more physiological model for the 
time span of 11 weeks may not have been aggressive enough in this model to elicit a 
robust inflammatory response, as the percentage of calories from fat (34% of kcals) or the 
composition of fat (primarily milk fat) may not have been adequate, to induce a severe 
case of obesity and inflammation. Future studies should examine the effect of different 
polyphenols or fractions present in grapes on obesity and systemic and intestinal 
inflammation using a diet induced obesity mouse model fed a diet that is more 
representative of the fat composition of the typical American diet (i.e., a mixture of 
animal and vegetable fats consisting of beef tallow, lard, milk fat, shortening, and 
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LF, low fat control; HF-3S, high fat- 3% sugar control; HF-3G, high fat- 3% grapes; HF-









Mean ± SEM without a common lower case letter in a column differ (p<0.050 using one-
way ANOVA and Student’s t test.  BWG = total body weight gain (g). FI= total food 
intake per cage (g). FCE= food conversion efficiency per cage. Kcal= total caloric intake 
per cage (kcals).  
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Figure 3.1. Diet Induced Changes to Fat Mass. Adiposity indices of C57BL/6J mice 
fed a low fat diet or butter-rich, high fat diets with or without 3% or 5% powdered grapes 
for 10 weeks.  (A) Body fat percentages were measured at week 5 and week 10 using 
dual energy x-ray absorptiometry (DEXA).  (B) At week 11, epididymal, inguinal, 
retroperitoneal, and mesenteric white adipose tissue (WAT) depots were excised and 
weighed (B). The weights of the epididymal, inguinal, retroperitoneal, and mesenteric 
depots were measured, and their sum labelled total WAT.  Means ± SEM without a 
common lowercase letter differ (p<0.05) using one-way ANOVA and Student’s t test.  
Means ± SEM (n=9-10) sharing the symbol “*” differ using the Bonferroni’s adjustment 
(p<0.01).; LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet containing 





Figure 3.2. Glucose Tolerance Tests. Glucose tolerance tests (GTT) s of C57BL/6J 
mice fed a low fat diet or butter-rich, high fat diets with or without 3% or 5% powdered 
grapes for 10 weeks.  At weeks 3, 6, and 9, GTTs were conducted on mice fasted for 8 h 
and injected i.p. with a 20% glucose solution.  Data are expressed as total area under the 
curve (AUC) for the GTTs. Means ± SEM (n=9-10) without a common lowercase letter 
differ (p<0.05) using one-way ANOVA and Student’s t test.  LF, low fat; 3S, high fat diet 
containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat diet containing 






Figure 3.3. Liver Gene Expression. (A) Liver weights, (B) liver triglyceride levels, and 
(C) the expression of several lipogenic genes in liver of C57BL/6J mice fed a low fat diet 
or butter-rich, high fat diets with or without 3% or 5% powdered grapes for 10 weeks.  
qPCR was conducted to measure mRNA abundance of genes associated with hepatic 
lipogenesis. Means ± SEM (n=9-10) without a common lowercase letter differ (p<0.05) 
using one-way ANOVA and Student’s t test.   LF, low fat; 3S, high fat diet containing 
3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat diet containing 5% sugar; 






Figure 3.4.  WAT Gene Expression. The expression of markers of inflammation and 
lipid metabolism in epididymal and inguinal WAT of C57BL/6J mice fed a low fat diet 
or butter-rich, high fat diets with or without 3% or 5% powdered grapes for 10 weeks.  
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qPCR was conducted to measure mRNA abundance of genes associated with 
inflammation in (A) epididymal (EPI; visceral) and (B) inguinal (ING; subcutaneous) 
WAT depots and also mRNA abundance of genes associated with lipid metabolism in (C) 
epididymal (EPI; visceral) and  (D) inguinal (ING; subcutaneous) WAT depots.  Means ± 
SEM (n=9-10) without a common lowercase letter differ (p<0.05) using one-way 
ANOVA and Student’s t test.  LF, low fat; 3S, high fat diet containing 3% sugar; 3G high 
fat diet containing 3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet 






Figure 3.5. Alterations to Intestinal Inflammation and Barrier Function. (A) Ileum 
mucosa expression of TNFα and (B) the localization of the tight junction protein ZO-1 at 
the apical area of the ileum epithelium in C57BL/6J mice fed a low fat diet or butter-rich, 
high fat diets with or without 3% or 5% powdered grapes for 10 weeks. qPCR was 
conducted to measure mRNA abundance of inflammatory genes.  Localization of ZO-1 
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was visualized by immunostaining of ileum samples (n=5).  Means ± SEM (n=9-10 for 
TNFα) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 
Student’s t test.   LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet 
containing 3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 






Figure 3.6. Diet Induced Alterations to Sulfidogenic Bacteria and Akkermansia 
muciniphilia. Abundance of sulfidogenic bacteria and Akkermansia muciniphilia in the 
intestinal mucosa or digesta of C57BL/6J mice fed a low fat diet or butter-rich, high fat 
diets with or without 3% or 5% powdered grapes for 10 weeks.  (A) Abundance of the 
sulfidogenic, Bilophila wadsworthia-specific, functional gene target dissimilatory sulfate 
reductase (dsrA-Bw) and the targeted sulfidogenic bacterial genera Desulfobacter (DSB) 
species in the ileum mucosa.  (B) The abundance of the probiotic Akkermansia 
muciniphilia in colon mucosa and digesta and in cecum digesta.  qPCR was conducted to 
measure mRNA abundance of the functional genes and bacterial genera.  Means ± SEM 
(n=9-10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 
Student’s t test.  LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet 
containing 3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 





Figure 3.7. Diet Induced Changes to Microbial Species. Observed bacterial species in 
cecum mucosa of C57BL/6J mice fed a low fat diet or butter-rich, high fat diets with or 
without 3% or 5% powdered grapes for 10 weeks. (A) Rarefaction curves of observed 
species are shown. Samples were rarified to 15,000 sequencing reads per sample. (B) 
Above - Area Under the Curve (AUC) of rarefaction curves shown for each diet group. 
Below – Observed species at 15,000 sequencing reads for each diet group. LF, low fat; 
3S, high fat diet containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat 
diet containing 5% sugar; 5G, high fat diet containing 5% grapes. Data are presented as 
Means ± SEM (n=9-10) using one-way ANOVA and Dunn’s test for multiple 





Figure 3.8. PCoA Plots of Unweighted and Weighted UniFrac Distances. LF, low fat; 
3S, high fat diet containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat 






Figure 3.9. Relative Abundance of Microbial Taxa. Significantly altered relative 
abundances of microbial taxa (i.e., A- Firmicutes, B- Actinobacteria, and C- Tenericutes) 
found across C57BL/6J mice fed a low fat diet or butter-rich, high fat diets with or 
without 3% or 5% powdered grapes for 10 weeks.  Taxa shown were significantly altered 
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based on Kruskal Wallis test run using QIIME software following filtering of OTUs that 
were not present in 50% of samples. FDR corrected p values based on this analysis are 
shown. To conduct multiple comparisons relative abundances were analyzed via 
ANOVA followed by Dunn’s test for multiple comparisons. LF, low fat; 3S, high fat diet 
containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat diet containing 
5% sugar; 5G, high fat diet containing 5% grapes.  Data are presented as Means ± SEM 
(n=9-10). Unless otherwise indicated, asterisks show significant differences of HF diets 





Figure 3.10. Principle Component Analysis (PCA) of Cecum Mucosa. The microbial 
relative abundances from C57BL/6J mice fed a low fat diet or butter-rich, high fat diets 
with or without 3% or 5% powdered grapes for 10 weeks. (A) Left - PCA plot between 
low fat (LF) and high fat + 3% grapes (HF3G) are shown. Middle – Pareto plot showing 
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percentage of variance explained by principal components. Right – Histogram showing 
individual genera that were negatively or positively correlated with LF and/or HF-3G 






Figure 3.11. Relationship between Body Fat and Bacterial Populations. (A) 
Bifidobacterium relative abundance is negatively correlated with body fat percentage (r = 
-0.53, p = 0.001) and inguinal fat pad weight (r = -0.48, p = 0.004) as determined by 
Spearman Correlation Analysis. (B) Heatmap showing relative abundances of taxa that 
were significantly correlated with body fat percentage.  LF, low fat; 3S, high fat diet 
containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat diet containing 







1. Ogdan CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Childhood and Adult 
Obesity in the United States, 2011-2012. JAMA 2014;311(8):806-814.  
 
2. WHO. Obesity. http://www.who.int/topics/obesity/en/. Viewed. Jan. 20, 2015. 
 
3. NIH. Obesity. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004552/. 
Viewed Jan. 20, 2015. 
 
4. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell 
recruitment and Th1 polarization in adipose tissue during diet-induced obesity in 
C57BL/6 mice. Obesity (Silver Spring) 2010;18(10): 1918-1925.  
 
5. Ding S, Chi M, Scull M, Rigby R, Schwerbrock N, Magness S, Jobin C, Lund P. 
High fat diet: bacterial interactions promote intestinal inflammation which 
precedes and correlates with obesity and insulin resistance in mice.  PLOS One 
2010;5(8): e12191. 
 
6. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. 
Communicable ulcerative colitis induced by T-bet deficiency in the innate 
immune system. Cell 2007;131(1):33-45. 
 
7. Cani P, Amar J, Iglesias M, Poggi M, Knauf C, Bastelica D, Neyrinck N, et al. 
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56: 
1761-1772. 
 
8. Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N, Barcelona R. 
Changes in gut microbiota control metabolic endotoxemia-induced inflammation 
in high-fat diet-induced obesity and diabetes in mice.  Diabetes 2008;57: 1470-
1481. 
 
9. Delzenne N, Cani P.  Gut microbiota and pathogenesis of insulin resistance. Cur 




10. Devkota S, Wang Y, Musch M, Leone V, Fehlner-Peach Hl, Nadimpalli A, et al. 
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in 
IL10-/- mice.  Nature 2012;487:104-108. 
 
11. Shen W, Gaskins HR, McIntosh M. Influence of dietary fat on intestinal 
microbes, inflammation, barrier function, and metabolic outcomes.  J Nutr 
Biochem 2014;25: 270-280. 
 
12. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between 
gut microbiota, host genetics, and diet relevant to development of metabolic 
syndromes in mice.  ISME J 2010;4: 232-241. 
 
13. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial 
pathways in colonic sulfur metabolism and links with health and disease. Front 
Physiol 2012;3: 448.  
 
14. Rowan FE, Docherty NG, Coffey JC, O’Connell PR. Sulphate-reducing bacteria 
and hydrogen sulphide in the aetiology of ulcerative colitis. Br J Surg 2009;96(2): 
151-158.  
 
15. Backhed F, Manchester J, Semenkovich C, Gordon J. Mechanisms underlying the 
resistance to diet-induced obesity in germ-free mice.  Proc Nat Acad Sci 
2007;104: 979-984. 
 
16. Delzenne N, Neyrinck A, Backhed F, Cani P. Targeting gut microbiota in 
obesity: effects of prebiotics and probiotics.  Nat Rev Endocrin 2011;7: 639-646. 
 
17. Delzenne N, and Cani P. Interaction between obesity and gut microbiota: 
relevance to nutrition. Ann Rev Nutr 2011b;31: 15-31. 
 
18. Delzenne N, Neyrinck A, Cain P.  Modulation of the gut microbiota by nutrients 
with prebiotic properties: consequences for host health in the context of obesity 
and metabolic syndrome. Micro Cell Fact 2011; 10: S10 
http://microbialcellfactories.com/content/10/S1/S10. 
 
19. Cani P, Neyrinck N, Fava F, Knauf C, Burcelin R, Tuophy K, et al. Selective 
increases of bifidobacteria in the gut microbiota improve high-fat-diet induced 
diabetes in mice through a mechanisms involving endotoxemia.  Diabetolgia 
2007;50: 2374-2383. 
 
20. Keperman R, Bolca S, Roger L,  Vaughan E. Novel approaches for analyzing gut 





21. Neyrinck A, Van Hee V, Bindels L, Possemiers S, de Backer F, Cani P, et al. 
Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and 
hypercholesterolemia in high-fat-induced obese mice: potential implication of the 
gut microbiota. Br J Nutr 2013;109:802-809.  
 
22. Benn T, Kim B, Park YK, Wegner C, Harness E, Nam TG, et al.   Polyphenol-
rich blackcurrant extract prevents inflammation in diet-induced obese mice.  J 
Nutr Biochem 2014;25: 1019-1025. 
 
23. Van Duynhoven J, Vaughan E, Jacobs D, Kemperman R, van Velzen E, Gross G, 
et al. Metabolic fate of polyphenols in the human superorganism.  Proc Nat Acad 
Sci 2011;108: 4531-4538. 
 
24. Selma M, Espin J, Tomas-Barberan F. Interactions between phenolics and gut 
microbiota: role in human health. J Agric Food Chem 2009;57: 6485-6501. 
 
25. Chuang CC, and McIntosh MK. Potential mechanisms by which polyphenol-rich 
grapes prevent obesity-mediated inflammation and metabolic diseases.  Ann Rev 
Nutr 2011;31: 155-176. 
 
26. Seymour E, Singer A, Bennink M, Parikh R, Kirakosyan A, Kaufman P, Broiling 
S.  Chronic intake of phytochemical-enriched diet reduces cardiac fibrosis and 
diastolic dysfunction caused by prolonged salt-sensitive hypertension. J Gerontol 
A Biol Sci Med Sci 2008; 63:1034-1042. 
 
27. Seymour EM, Bennink MR, Watts SW, Bolling SF. Whole grape intake impacts 
cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB 
activity and cytokine expression in rats with diastolic dysfunction. Hypertension 
2010;55:1179-85. 
 
28. Fuhrman B, Volkova N, Coleman R, Aviram M. Grape powder polyphenols 
attenuate atherosclerosis development in apolipoprotein E deficient mice and 
reduce macrophage atherogenicity.  J Nutr 2005; 135:722-728. 
 
29. Zern T, Wood R, Greene C, West K, Liu Y, Aggarwal, et al. Grape polyphenols 
exert a cardioprotective effect in pre- and postmenopausal women by lowering 
plasma lipids and reducing oxidative stress.  J. Nutr 2005; 135:1911-1917. 
 
30. Chuang CC, Shen W, Chen H, Xie G, Jia W, Chung S, McIntosh MK.  
Differential effects of grape powder and its extract on glucose tolerance and 





31. Shen W, Chuang CC, Martinez K, Reid T, Brown JM, Xi L, et al. Conjugated 
Linoleic Acid Reduces Adiposity and Increases Markers of Browning and 
Inflammation in White Adipose Tissue of Mice. J Lipid Res 2013; 54: 909-922. 
 
32. Shen W, Wolf PG, Carbonero F, Zhong W, Reid T, Gaskins HR, McIntosh MK. 
Intestinal and systemic inflammatory responses are positively associated with 
sulfidogenic bacteria abundance in high-fat-fed male C57BL/6J mice.  J Nutr 
2014; 144: 1181-87. 
 
33. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Frederic BD, Costello EK, 
et al. QIIME allows analysis of high-throughput community sequencing data. Nat 
Methods 2010;7:335–6. doi:10.1038/nmeth.f.303 
 
34. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. 
An improved Greengenes taxonomy with explicit ranks for ecological and 
evolutionary analyses of bacteria and archaea. ISME J 2012;6: 610-618.  
 
35. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve Bayesian Classifier for Rapid 
Assignment of rRNA Sequences into the New Bacterial Taxonomy. Appl Envir 
Microbiol 2007;73: 5261-5267.  
 
36. Price MN, Dehal PS, Arkin AP.  FastTree 2 – Approximately Maximum-
Likelihood Trees for Large Alignments. PLoS One 2010; 5, e9490.  
 
37. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, 
Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD. Cross-talk 
between Akkermansia muciniphila and intestinal epithelium controls diet-induced 
obesity. Proc Nat Acad Sci 2013; 110(20): 9066-71. 
 
38. Camari A, del Bas JM, Crescenti A, Arola L. Low doses of grape seed 
procyanidins reduce adiposity and improve the plasma lipid profile in hamsters. 
Int J Obes (Lond) 2013;37(4): 576-83.  
 
39. Gourineni V, Shay NF, Chung S, Sandhu AK, Gu L. Muscadine Grape (Vitis 
rotundifolia) and Wine Phytochemicals Prevented Obesity-Associated Metabolic 
Complications in C57BL/6J Mice. J Agric Food Chem 2012;60(31): 7674-81. 
 
40. Hwang YP, Choi JH, Han EH, Kim HG, Wee JH, Jung KO, Jung KH, Kwon KI., 
Jeong TC, Chung YC, Jeong HG. Purple sweet potato anthocyanins attenuate 
hepatic lipid accumulation through activating adenosine monophosphate-





41. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between 
gut microbiota, host genetics, and diet relevant to development of metabolic 
syndromes in mice. ISME J 2010;4: 232-241. 
 
42. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial 
pathways in colonic sulfur metabolism and links with health and disease. Front 
Physiol 2012;3:448. 
 
43 U.S. Department of Agriculture; Agricultural Research Service; Beltsville Human 
Nutrition Research Center; Food Surveys Research Group (Beltsville MD) and; 
U.S. Department of Health and Human Services; Centers for Disease Control and 
Prevention; National Center for Health Statistics (Hyattsville MD). What We Eat 





AN EXTRACTABLE, POLYPHENOL-RICH FRACTION OBTAINED FROM 
CALIFORNIA TABLE GRAPES DECREASES ADIPOSITY, INSULIN 




     Jessie Baldwin, Brian Collins, Chia-Chi Chuang, Paula Cooney, Robin Hopkins, and  




     The objective of this study was to determine the extent to which consuming two 
methanol-extractable fractions of California table grapes reduced adiposity, hepatic 
steatosis, or markers of inflammation or lipid metabolism in mice fed a high-fat, 
American-type diet.  Male C57BL/6J mice were fed a low fat diet, a high fat (HF) diet, or 
a HF diet containing California table grapes (GP; 5% w/w), an extractable polyphenol 
(HF-EP) fraction from GP, a non-extractable polyphenol (HF-NEP) fraction from GP, or 
an equal combination of both fractions (HF-EP+NEP) for 16 weeks. Mice fed the HF-EP 
and HF-EP+NEP-containing diets had lower percentages of body fat and amounts of total 
white adipose tissue (WAT) and improved glucose tolerance compared to the HF 
controls.  In epididymal WAT, the mRNA levels of the inflammatory genes cluster of 
differentiation 11c, monocyte chemoattractant protein 1, epidermal growth factor-like 
module-containing mucin-like hormone receptor 1, tumor necrosis factor alpha, and the 
lipogenic gene, acylglycerol-3-phosphate-O-acyltransferase 2 were lower in mice fed the
78 
 
HF-EP- and HF-EP+NEP-containing diets compared to HF controls.  Mice fed HF-NEP 
and HF-EP+NEP diets had reduced liver weights and mice fed HF-EP+NEP diets 
hadlower liver triglyceride levels compared to the HF controls. Mice fed the HF-EP+NEP 
diets had higher hepatic mRNA levels of hormone sensitive lipase and adipose 
triglyceride lipase, and decreased expression of c-reactive protein compared to the HF 
controls.  Surprising, HF-GP feeding neither decreased adiposity, hepatic steatosis, or 
inflammation nor did the HF or grape diets alter markers of intestinal inflammation.  
Taken together, these data demonstrate that the polyphenol-rich EP fraction from 
California table grapes attenuates many of the adverse health consequences associated 
with consuming a HF diet, independent of influencing intestinal inflammatory status. 
 
Introduction 
     Obesity has been on the rise in the U.S. since the 1960’s and affects approximately 
one third of the adult population [1]. The incidence of obesity is also increasing globally, 
affecting approximately 300 million adults worldwide [2]. Obesity is intimately 
associated with chronic inflammatory conditions that contribute to the metabolic 
syndrome (e.g., type 2 diabetes, hypertension, and cardiovascular disease) [3].  Over 
consumption of calories coinciding with a lack of physical activity are the major risk 
factors for obesity development resulting in expansion of white adipose tissue (WAT). As 
WAT grows beyond the capacity of the vasculature system to provide it with nutrients 
and oxygen, inflammatory signals recruit macrophages and other immune cells into the 
WAT. As the immune response progresses, the abundance of circulating and tissue 
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proinflammatory cytokines and chemokines increases [4]. This inflammatory scenario 
disrupts metabolic processes which results in impaired glucose and fatty acid uptake and 
metabolism, and hemostasis, thereby contributing to the development of metabolic 
diseases. Although there is a general consensus on the metabolic consequences of 
obesity-mediated inflammation, the exact mechanisms that initiate these events are not 
clearly understood. 
     Recently, the role that gut microbes play in the development of the metabolic 
syndrome has received attention due to their sensitivity to environmental changes that can 
trigger obesity [5], chronic inflammation [6-8], and insulin resistance [9]. Diets high in 
fat have been implicated in the reduction of microbial diversity, in particular gut barrier-
protecting bacteria as well as increasing the abundance of deleterious bacteria [reviewed 
in 10]. For example, an increase in the ratio of Firmicutes to Bacteriodetes is positively 
correlated with the development of obesity and insulin resistance [11]. Diets rich in 
saturated fat [11, 12], particularly from milk [13], increase the abundance of sulfidogenic 
bacteria like Bilophila wadsworthia and Desulfovibrionaceae spp. which generate 
hydrogen sulfide gas.  Hydrogen sulfide is geno- and cytotoxic and positively correlated 
with development of ulcerative colitis, gut inflammation, irritable bowel syndrome, and 
colon cancer [13-15].  Notably, the effects of high fat (HF) diet on body weight gain are 
repressed in microbiota-free mouse models as well as fecal microbial transplants from 
healthy donors into obese subjects [16].  Therefore, interventions directed towards 




     The use of non-digestible carbohydrates, fiber, or polyphenols as prebiotics shows 
promise as potential interventions for the metabolic consequences of obesity [reviewed in 
13, 17-19]. Prebiotics are agents that selectively stimulate the growth or activities of 
specific microbial populations in the gut which translates into health benefits for the host 
[20].  Fiber, in particular inulin-type fructans, has been shown to increase the abundance 
of Bifidobacteria which was positively correlated with decreased hyperglycemia, 
endotoxemia, and systemic cytokine levels [21, 22].  Similar effects have been 
demonstrated in obese subjects with short term supplementation of gluco-
oligosaccharides [23]. It is believed that the primary benefit of fiber fermentation by 
intestinal microbes is through increased productions of short chain fatty acids (SCFA), 
which have be shown to regulate the synthesis of GI peptides that influence energy intake 
(i.e., glucagon-like peptide (Glp)-1 and 2, peptide YY (Pyy), and ghrelin) as well as 
energy storage and metabolism through interactions with G-protein receptors (Gpr) 41 
and 43 [reviewed in 20].   
     Although much focus has been placed on the beneficial properties of fiber, 
polyphenols found in fruits and vegetables may also improve GI health [24-27].  
Absorption of polyphenols is poor in the upper gastrointestinal tract, leading to increased 
availability in the lower GI tract [27]. Thus, polyphenols may have a significant influence 
on microbiota taxa and their metabolites [28]. Indeed, the anti-inflammatory, anti-
oxidant, and anti-microbial actions of polyphenols have been reported to positively 
influence gut microbes and host inflammation [reviewed in 29]. As such, one potential 
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mechanism to improve the outcomes associated with diet-induced obesity is increased 
consumption of poorly digestible food components including polyphenols. 
     Grapes and other berries are rich in polyphenols including anthocyanins [reviewed in 
29], which have known anti-inflammatory and anti-oxidant effects [30]. These beneficial 
effects of grapes have been associated with reduced cytokine levels via suppression of 
nuclear factor kappa B (NFκB) and increased peroxisome proliferator-activated receptor 
(PPAR)α/γ [31]. Consistent with these data, we demonstrated that C57BL/6J mice 
consuming a HF diet (i.e., 60% kcals from lard) supplemented with whole powdered 
California table grapes  (3%, w/w) had improved glucose tolerance after 5 weeks and  
decreased markers of inflammation ~20-50% in serum and WAT after 18 weeks [32].  
We also demonstrated that consuming a moderate fat diet (i.e., 34% kcals from milk fat) 
supplemented with whole powdered grapes (3% or 5% w/w) reduced adiposity, improved 
liver triglyceride (TG) levels, modestly reduced WAT inflammatory gene expression, and 
lowered the cecum levels of sulfidogenic bacteria, while tending to increase the 
abundance of Akkermansia muciniphalia and Allobaculum in the proximal colon and 
cecum, respectively (Chapter III).  
     However, the identities of the bioactive fractions in whole powdered table grapes and 
the role that gut microbiota play in improvements in diet-induced obesity in mice fed 
grapes are unknown. Therefore, the objective of this study was to determine the extent to 
which consuming methanol-extractable fractions of table grapes reduced adiposity, 
hepatic steatosis, or markers of inflammation or lipid metabolism in mice fed a high-fat, 
American-type diet. We separated lyophilized powder from whole grapes into two 
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methanol-extractable fractions; i.e., an extractable polyphenol (EP) fraction and a non-
extractable polyphenol (NEP) fraction. These fractions were incorporated into a HF, 
American-type diet (i.e., similar in fat amount and type to the 75th percentile of 
American diets [33]).  This HF diet was fed alone or in combination with the EP fraction, 
the NEP fraction, both fractions (EP+NEP), or whole grape powder (GP; 5%, w/w) for 16 
weeks. Body composition and glucose tolerance were measured at 5 week intervals.  At 
week 16, markers of intestinal and systemic inflammation, insulin resistance, and lipid 
metabolism were measured. 
 
Materials and Methods   
Reagents and materials  
     Reference compounds procyanidin A2 (PAC-A2), procyanidin B2 (PAC-B2), catechin 
and epicatechin were purchased from Chromadex (Irvine, CA).  4-
dimethylaminocinnamaldehyde (DMAC), Folin-Ciocalteu reagent, and trifluoroacetic 
acid (TFA) were purchased from Sigma-Aldrich Inc. (St. Louis, MO). All organic 
solvents were HPLC grade and obtained from VWR International (Suwanee, GA).  
 
Extraction and polyphenol enrichment 
     Freeze-dried grape powder (200 g x 5 batches) was blended each with 1 L 50% 
acidified methanol (0.1% TFA).  The mixture was centrifuged (Sorvall RC-6 plus, 
Asheville, NC) at 4000 rpm for 10 min, and the supernatant was collected. A sample 
from the combined supernatants (2 L) was evaporated and freeze-dried to afford the 
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crude extract. The rest of aq-methnol extract was evaporated to remove the organic 
solvent, and then loaded to Amberlite XDA-7 resin, stirred for 20 minutes, and the 
supernatant was discarded. The resin was washed with water to get rid of all free sugars 
and organic acids. The polyphenols were eluted from the resin with 100% methanol, 
organic solvent was evaporated under vacuum, and the remaining aqueous extract was 
freeze-dried to afford the EP fraction. The pelleted material (plant debris after extraction) 
was put in a vacuum oven (45 ºC) to get rid of the organic solvent before freeze-drying to 
afford the NEP fraction. 
 
Alkaline hydrolysis of NEP fraction 
     Alkaline hydrolysis of NEP fraction was performed according to Yang et al. [34] with 
some modifications. In 15 mL centrifuge tube, 2.0 mL of 4 M NaOH were added to 0.5 g 
NEP, flushed with nitrogen, closed and incubated for 1 hour at room temperature. The 
mixture was adjusted to pH 7 with drops of concentrated hydrochloric acid, than loaded 
onto a column packed with celite at a ratio 1:2 v/w.  The hydrolyzed polyphenols were 
eluted with 30 mL methanol-ethyl acetate (20:80 v/v), and evaporated to dryness. 
Determination of total phenolics, anthocyanins and proanthocyanidins 
     Total phenolics (TP) were determined in EP and NEP fraction hydrolysates with 
Folin-Ciocalteu reagent [35]. Concentrations were expressed as mg/L gallic acid 
equivalents. Total monomeric anthocyanin (ANC) content was measured in EP using the 
pH differential spectrophotometric method [36], and expressed as cyanidin glucoside 
equivalent. Total proanthocyanidin content (PAC) was determined in EP using the 
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DMAC method as previously described [37], and quantified as procyanidin A2 
equivalent. 
 
HPLC profile analyses of anthocyanins and proanthocyanidins 




     Four-week old, male C57BL/6J mice were obtained from Jackson Laboratories (Bar 
Harbor, ME, USA) and acclimated on a standard chow diet for 1 week. Mice were 
housed in pairs, maintained at a temperature of 22◦C with 50% humidity, and exposed to 
a 12 h light/ 12 h dark cycle. Mice received food and water ad libitum and measures of 
body weight and food intake were conducted once and twice per week, respectively. All 
experimental procedures were performed under ethical standards and approved by the 




     Animals were randomly assigned to one of six dietary treatments (n=13 per treatment 
group) as follows: low fat (LF; 10% of energy from fat), HF (45% of energy from fat), 
HF plus extractable polyphenol fraction (HF-EP), HF plus non-extractable polyphenol 
fraction (HF-NEP), HF plus extractable and non-extractable polyphenol fraction (HF-
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EP+NEP) and HF plus 5% powdered grapes (HF-GP) (Table 4.1) . The HF diets 
consisted of approximately 10.7% energy from soybean oil, 9.8% of energy from butter, 
7.8% energy from lard, 12.2% energy from shortening, and 4.5% energy from beef tallow 
[33, 39]. Thus, the HF diets were rich in fat with the proportion of the sources of fat 
mimicking an American-type diet [33]. The amounts of EP and NEP fractions that were 
added to the HF diets were equal to their relatively amounts in the in the 5% powdered 
whole grape diet (i.e., grape powder contains 2.3% and 6.9% EP and NEP, respectively). 
The lyophilized (i.e., powdered) California table grapes were kindly provided by the 
California Table Grape Commission and consisted of a mixture of red, green, and purple 
seeded and seedless grapes. The 5% dietary level of grapes is comparable to 15 human 
servings of grapes. Because the extraction process removes the sugar fraction in grapes, a 
mixture of fructose and glucose was added to the HF, HF-EP, HF-NEP, and HF-EP+NEP 
diets to control for the sugar content of the powdered grape diet. Detailed composition of 
the diets is illustrated in Table 4.1.  
 
Intraperitoneal glucose tolerance tests (GTT)s, and fasting insulin levels  
     Intraperitoneal (i.p.) GTTs were performed on weeks 7, 12, and 16 on non-
anesthetized mice. Mice were fasted for 8 h and given an i.p. injection of glucose (i.e., 
20% solution at 1 g/kg body weight). Blood from the tail vein collected at baseline and 5, 
15, 30, 60, and 120 minutes post-i.p. glucose injection was used to quantify glucose 
levels using a Bayer Contour blood glucose monitor and strips (Bayer Healthcare, 
Tarrytown, NY, USA). Plasma insulin levels were detected using an ultrasensitive mouse 
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insulin kit (Crystal Chem, Inc, Downers Grove, IL). The homeostasis model assessment 
method (HOMA) for insulin resistance (IR) was used employing the following formula: 
[fasting insulin concentration (ng/ml) x 24 x fasting glucose concentration (mg/dl)] / 405 
[32]. 
 
Body fat measurements via Dual X-Ray Absorptiometry (DEXA) 
     Percent body fat was measured using DEXA on a GE Lunar Prodigy Advanced 
System (GE Healthcare, Milwaukee, WI) at weeks 6, 11, and 15. During the 
measurement, mice were lightly anesthetized with isoflurane using a SomnoSuite Small 
Animal Anesthesia System with Integrated Digital Vaporizer isoflurane system. 
Measurements were taken in duplicate or triplicate to reduce the possibility of error and 
values expressed are an average of the two measurements.  
 
Tissue collection 
     After 16 weeks of dietary intervention, mice were fasted for 8 h and euthanized via 
isoflurane-induced anesthesia followed by cardiac puncture. Plasma was collected at the 
time of harvest. Four WAT depots were collected; epididymal, mesenteric, inguinal, and 
retroperitoneal. Additionally, livers were harvested and intestinal mucosa and digesta 
were collected from the duodenum, jejunum, ileum, cecum, or proximal or distal colon. 
Weights of the WAT depots and liver were recorded and all collected samples were 
immediately snap-frozen in liquid nitrogen and stored at -80oC until analysis.  
Liver and plasma TG levels 
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     Liver TG content was measured as previously described [40]. Plasma TG content was 
determined using a commercial assay from Thermo Scientific and was conducted 
following the manufacturer’s protocol (Infinity TG assay #TR22421 and TG standards 
#TG22923; Norcross, GA).  
 
Liver Oil-Red-O Staining 
     Liver tissues were frozen in OCT compounds, cut at 5 μm, and mounted on slides. 
The sections were fixed with 10% formalin for 10 minutes and then the slides were 
washed with deionized water for 5 minutes. Fixed tissues were then rinsed with 60% 
isopropanol for 5 minutes. To prepare Oil red O stock, 0.5 g of Oil red O (Sigma-
Aldrich) was mixed with 100 mL of isopropanol. To prepare Oil red O working solution, 
30 mL of Oil red O stock was mixed with 20 mL of distilled water and filtered using a 
0.24 µm vacuum filter. Samples were submerged in the working solution for 15 minutes, 
briefly rinsed with 60% isopropanol, and then rinsed with deionized water for 30 seconds 
before imaging. 
 
RNA extraction and qPCR 
     Adipose and intestinal samples were homogenized in QIAsol reagent and total RNA 
was extracted using QIAgen mini lipid kit obtained from Qiagen (Valencia, CA). For 
hepatic samples, a QIAgen mini universal kit from Qiagen was used. The quality and 
concentration of RNA were examined using absorbance at 260 nm and integrity 
determined using the absorbance ratio of 260/280 on a Nanodrop ND-1000 
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Spectrophotometer (Thermo Scientific, Wilmington, DE). Complementary DNA was 
created by reverse transcription using 1 ug of RNA and a high capacity cDNA Archive 
Kit (Applied Biosystems, Foster City, CA) according to manufacturer’s protocols. qPCR 
was performed in a 7500 FAST Real Time PCR system (Applied Biosystems). The 
expression of different genes related to inflammation, lipogenesis, and lipolysis in WAT 
depots and liver were measured using Taqman Gene expression assays purchased from 
Applied Biosystems. TATA-binding protein (Tbp) was the endogenous reference gene 
utilized for all assays and fold differences in gene expression were calculated as 2−ΔΔCt. 
 
Statistical Analysis 
     Data were analyzed using a one-way ANOVA and Student’s t tests to compute 
individual pairwise comparisons of means (p<0.05). Bonferroni’s posthoc tests were also 
performed for specific comparisons where appropriate. Analyses were conducted using 
the JMP software program version 10.0 for Windows (SAS, Cary, NC).  Data are 
expressed as means + S.E.M. 
 
Results  
Polyphenol content and profile of EP, NEP, and GP 
     Polyphenol analysis revealed that the weight percentages of polyphenols in the EP and 
NEP fractions were 2.26% and 6.91% respectively.  The EP fraction contained 180.0 
mg/g of total phenolics and the NEP fraction contained 10.5 mg/g of total phenolics.  
Total anthocyanin and proanthocyanidin content of the EP fraction was 37.8 mg/g and 
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305.5 mg/g, respectively, whereas these polyphenols were not detectable in the NEP 
fraction (Table 4.2). Individual anthocyanin analysis revealed that the most abundant 
anthocyanins present in the EP fraction were peonidin-3-O-glucoside (36.6 u/mg), 
malvidin-3-O-glucoside (30.8 u/mg), and peondin-3-O-cis (6”-O-p-coumaryl)-glucoside 
(28.5 u/mg) (Table 4.3). The profile of the degree of polymerization of the 
proanthocyanidins in the EP fraction is shown in (Fig. 4.1).  
 
EP fraction with or without NEP fraction lowers body fat gain  
     Body weight gains and energy intakes were greater in all HF-fed mice compared to 
the LF control mice (Table 4.4).  There was no difference in the energy intake between 
all of the HF-fed mice, with the exception of the HF-EP+NEP group that consumed 
approximately 10% fewer calories than the HF controls (Table 4.4). Mice fed the HF-EP 
and HF-EP+NEP diets had lower body weight gains (Table 4.4; ~28% and 40%, 
respectively) and body fat percentages than the HF controls (Fig. 4.2; 27% and 37%, 
respectively). Mice fed the HF-EP, HF-NEP and HF-EP+NEP diets had lower total WAT 
depot weights compared to HF controls (Fig.4.2).  Paradoxically, mice fed the HF-GP 
diet did not have improvements in body fat percentage, body weight, and total WAT 
depot weights compared to the HF controls.    
 
EP fraction improves glucose disposal, insulin resistance, and hypertriglyceridemia 
     To assess the impact of grape consumption on glucose disposal and insulin resistance, 
GTTs were conducted at weeks 7, 12, and 16, and fasting plasma insulin and HOMA-IR 
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were measured at week 16, respectively. Mice consuming the HF control diet had 
impaired GTTs at all three time points compared to the LF controls (Fig. 4.3A). This HF 
diet impairment was attenuated at all three time points in mice fed the HF-EP diet. Mice 
fed the HF-NEP and HF-EP+NEP diets had improved GTTs at weeks 12 and 16 
compared to the HF controls. HOMA-IR index calculations at week 16 indicated that 
mice consuming the HF-EP+NEP fraction had improved insulin sensitivity compared to 
the HF controls (Fig. 4.3B). Surprisingly, consuming grapes did not significantly 
improve GTT, fasting plasma insulin, and HOMA-IR measurements.  Mice fed the HF-
EP and the HF-EP+NEP diets had lower plasma TG levels compared to the HF-fed 
controls (Fig. 4.3C). 
 
Grape fraction consumption lowers hepatic TG levels and alters the expression of genes 
associated with lipid metabolism and inflammation  
     Liver tissue was analyzed to assess the impact of the diets on liver TG levels and 
markers of lipogenesis, lipolysis, and fatty acid oxidation. Mice consuming the HF 
control diet had greater liver weights, TG content, and mRNA levels of the lipogenic 
genes Pparγ and Fas compared to the LF-fed mice (Fig. 4.4).  Compared to LF controls, 
HF feeding also increased gene expression of stearoyl regulatory element binding protein 
1 (Srebp-1c), and stearoyl-CoA desaturase 1 (Scd1), which was not effected by whole 
grape or grape fraction feeding (Figure 4.4). Mice consuming the HF-NEP and HF-
EP+NEP diets had lower liver weights and mice consuming the HF-EP+NEP diet had 
lower liver TG content compared to HF controls. Mice fed the HF-EP and HF-EP+NEP 
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diets had greater mRNA levels of hormone sensitive lipase (Hsl), while mice fed the HF-
EP+NEP diet had increased mRNA levels of adipose triglyceride lipase (Atgl) compared 
to HF controls (Figure 4.4).  HF feeding increased the hepatic gene expression of the 
inflammatory marker C-reactive protein 1 (Crp1), which was attenuated by HF-EP and 
HF-EP+NEP feeding (Figure 4.4). Interestingly, all mice consuming HF diets had ~60% 
lower mRNA levels of phosphoenolpyruvate carboxykinase (Pck1), a marker of 
gluconeogenesis.  No treatment differences in the expression of carnitine 
palmitoyltransferase 1-a (Cpt1a) were detected (data not shown).  Hepatic oil-red-o 
staining indicated greater lipid content in the livers of mice fed the HF control diet 
compared to the LF controls, which was attenuated by HF-EP, HF-NEP, and HF-
EP+NEP consumption (Fig. 4.5).  
 
EP fraction with or without NEP fraction improves the expression of WAT genes 
associated with inflammation and lipid metabolism  
     To determine if the negative metabolic effects caused by HF-feeding were associated 
with inflammation in WAT, mRNA levels of several proinflammatory genes were 
measured in inguinal (subcutaneous) and epididymal (visceral) WAT.  In inguinal WAT, 
mice fed the HF control diet had greater mRNA levels of cluster of differentiation 11c 
(Cd11c) and monocyte chemoattractant protein 1 (Mcp1) compared to LF controls 
(Fig.4.6A).  This HF-induced increase was attenuated in mice fed the HF-EP and HF-
EP+NEP diets.  In epididymal WAT, HF-feeding increased mRNA levels of Cd11c, 
Mcp1, tumor necrosis factor alpha (TNFα), and epidermal growth factor-like module 
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containing mucin-like hormone receptor 1 (Erm1; F4/80 human orthologue) compared to 
LF controls (Fig. 4.6B).  Consistent with the inguinal data, mice fed the HF-EP and HF-
EP+NEP diets had lower mRNA levels of these genes compared to the HF controls.   
     To determine whether the reduction in adiposity observed with feeding of HF-EP, HF-
NEP, and HF-EP+NEP diets was associated in alterations in lipid metabolism, inguinal 
and epididymal WAT were examined for markers of; (i) lipogenesis (i.e., Pparγ, Srebp1c, 
Scd1, acylglycerol-3-phosphate-O-acyltransferase 2 (Agpat2), fatty acid synthase (Fas), 
glycerol-3-phosphate acyltransferase2 (Gpat2)), (ii) lipolysis (i.e., Atgl (iii) beta-
oxidation (i.e., carnitine palmitoyltransferase 1-b (Cpt1b), Pparα), (iv) SCFA receptors 
(i.e. GPR43), and (v) plasminogen activator inhibitor-1 (Pai-1). In inguinal WAT, mice 
fed the HF diet had greater expression levels of Agpat2, which were lower in the HF-EP 
and HF-EP+NEP groups (Fig. 4.7A). Cpt1b gene expression was lower in mice fed the 
HF-EP, HF-EP+NEP diets compared to the HF-fed mice. No treatment differences in 
gene expression were observed for Srebp1c, Scd1, Fas, Gpat2, Atgl, and Pparα.   
     In epididymal WAT, mice consuming the HF diet had higher mRNA levels of Agpat2, 
a marker of TG biosynthesis, compared to LF controls (Fig. 4.7B).  Feeding HF-EP and 
HF-EP+NEP attenuated this HF-induced increase in Agpat2 expression.  Additionally, 
mice fed the HF diet-had lower levels of Pparγ compared to LF controls. The expression 
of Pparα, a marker of beta oxidation, was reduced in mice fed the HF control and the GP 
diets compared to LF controls.  Surprisingly, HF feeding increase the mRNA levels of 
Cpt1b, beta-oxidation marker, which was reduced by HF-EP and HF-EP+NEP feeding. 
Additionally, mice fed the HF-EP+NEP diet had lower mRNA levels of GPR43, a SCFA-
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activated receptor associated with increased energy harvest, compared to HF- and LF-fed 
controls. No differences in gene expression in epididymal WAT were observed for 
Srebp-1c, Scd1, Fas, Gpat2, and Atgl (data not shown). 
 
Minimal influence of HF-feeding and grape fraction consumption on markers of 
intestinal inflammation  
     Given the reported adverse effects of consuming saturated fats [reviewed in 10] on 
intestinal health, and potential prebiotic impact of grapes, we measured the effects of the 
diets on markers of intestinal inflammation and barrier function. For inflammatory status, 
the mRNA levels of Cd11c, Cd68, Erm1, Mcp1, Tnfα, Tlr4, and interleukin (Il)1b in 
ileum and proximal colon mucosa and the activity of ileal myeloperoxidase were 
measured. Unexpectedly, the mRNA levels of proinflammatory genes were not increased 
in the ileal mucosa of HF- fed mice compared to the LF controls. Equally surprising, 
mice consuming the HF-GP diets had greater mRNA levels of Tlr4 and Cd68 compared 
to the HF-fed mice (Fig. 4.8A). Although the activity of myeloperoxidase, an enzyme 
expressed neutrophils and indicative of neutrophil infiltration, was ~50%  lower in the 
ileal mucosa of mice consuming the HF-EP and HF-EF+NEP diets compared to the HF-
fed mice, these differences were not statistically significant (Fig. 4.8A). Similarly, the 
expression of Tlr4 was greater in the colonic mucosa of HF- GP fed mice compared to 
the HF controls (Fig. 4.8B).  Two of the proinflammatory genes measured in the colonic 
mucosa where increased by HF feeding (i.e., Cd11c, Cd68) and only Cd68 was 
attenuated in mice consuming the HF-EP+NEP diet (Fig. 4.8B).  
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Influence of grape fractions on intestinal L-cell gene expression  
     Intestinal microbial metabolites impact local and systemic health, in part, by 
influencing fermentation products (e.g., SCFA), energy harvest, and the release of 
endocrine signals from L-cells located in the mucosa epithelium. Locally, these 
metabolites influence the integrity of the mucosa barrier and systemically impact energy 
balance and carbohydrate and lipid metabolism [20].  Therefore, we determined the 
influence of the dietary treatments on the induction of genes associated with SCFA 
receptors (e.g., Gpr41, -43, and -119) and two of their downstream targets (e.g., Glp and 
Pyy) in the ileum and proximal colon. Mice fed the HF-EP, HF-NEP, and HF-EP+NEP 
diets had greater mRNA levels Gpr43, but not Gpr41, in the ileum mucosa compared to 
the HF controls (Fig. 4.9A). Mice fed the HF-EP+NEP and the HF-GP diets had lower 
mRNA levels of Gpr41 in the ileum mucosa compared to the HF controls. Mice fed the 
HF-GP diet has the highest levels of Glp compared to all other treatments (Fig.4.9A). In 
contrast, mice fed the HF diet had higher mRNA levels of Gpr43 in the proximal colon 
compared to the HF-NEP, HF-EP+NEP, and HF-GP groups (Fig. 4.9B). Lastly, HF-
feeding increased Pyy mRNA levels in the proximal colon, which were lower in mice fed 




Rationale and significance of this study 
 
     We previously demonstrated that feeding whole GP in conjunction with a HF diet 
(i.e., 34% kcals from fat; 3% from soybean oil and 31% from milk fat, which was similar 
to the amount of fat consumed by Americans in the 50th percentile [33] for 10 weeks 
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modestly reduced adiposity (3% and 5% GP), hepatic steatosis (5% GP), and the ileal 
mucosa abundance of the deleterious sulfidogenic bacterium species DSB and a 
sulfidogenic gene drsA-Bw (3% GP),  and increased the proximal colon mucosa 
abundance of the beneficial bacterium Akkermansia muciniphila (5% GP) and the 
localization of the tight junction protein ZO-1 on the apical epithelial surface of the ileum 
(3% and 5% GP). However, consuming the HF diet for 10 weeks only modestly increased 
adiposity, insulin resistance, and several markers of inflammation in epididymal 
(visceral) WAT, and had no effects on markers of intestinal inflammation.  Therefore, we 
conducted the current 16 week study using a higher level of dietary fat (i.e., 45% kcals) 
and a fatty acid profile that was similar to Americans in the 75th percentile (i.e., soybean 
oil, butter, lard, shortening, and beef tallow [33] to enhance the metabolic consequences 
of diet-induced obesity. We also wanted to know which fraction of GP was responsible 
for reducing adiposity and its potential metabolic complications.  Therefore, we 
examined the effects of whole GP (i.e., 5%) and two isolated fractions of grapes (i.e. 
methanol derived EP and NEP fractions which were fed at amounts equal to those in 5% 
GP) on the development of obesity, steatosis, glucose intolerance, and WAT 
inflammation in C57BL/6J mice fed a HF diet similar to Americans. The EP fraction 
contained ~ 16 times more polyphenols, particularly anthocyanins (i.e., glucosides of 
anthocyanidins; Table 4.3) and proanthocyanidins (i.e., polymers of anthocyanidins 
formed by the condensation of flavans; Table 4.2) , than the NEP fraction. The results 
indicate that in the context of HF feeding, consumption of the polyphenol-rich, EP 
fraction, alone or in combination with the NEP fraction, attenuated diet-induced obesity, 
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insulin resistance, steatosis, and chronic inflammation in WAT.  However, consuming 
whole GP had no beneficial impact on the outcomes measured, and reasons for this lack 
of an effect are unclear.  
 
Potential mechanisms by which anthocyanin-rich EP fraction suppresses adiposity and 
inflammation and improves insulin sensitivity  
 
     Anthocyanins and proanthocyanidins are groups of flavonoids present in relatively 
large amounts in table grapes. Anthocyanins give these berries their unique colors.  Our 
phenolic analysis indicated that the most abundant anthocyanins found in California table 
grapes are malvidin-3-O-glucoside, peonidin-3-O-glucoside, and cyanidin-3-O-glucoside.  
While studies have demonstrated anti-obesity and anti-diabetic effects of anthocyanins 
[reviewed in 41], studies focusing on the effects of feeding whole grapes and grape 
fractions feeding in subjects consuming a diet similar in fat amount and types to the 
American diet are lacking.  Consistent with our anthocyanin-rich EP data, mice 
consuming a HF diet (i.e., 60% kcals from fat, primarily lard) supplemented with 
anthocyanin-rich muscadine grape or wine extracts for 15 weeks had lower body weights, 
plasma glucose and TG levels, insulin resistance, and CRP levels compared to controls 
[42].  Also, dietary supplementation of grape seed procyanidins has been demonstrated to 
prevent body weight gain, reduces WAT inflammatory markers (i.e. Tnfα, Il-6, Crp) in 
high-fat-fed rats [43].  Similar effects were observed with grape seed extract 
supplementation including reductions in weight gain, WAT weights and blood lipid 
levels in HF fed mice [44], and improvements insulin sensitivity and reductions in 
oxidative stress in high-fructose fed rats [45]. These findings are consistent with our data 
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demonstrating that EP-fed mice had less body weight gain, reduced WAT weights, lower 
plasma TG, improved insulin sensitivity, and reduced markers of inflammation in WAT 
(i.e. Cd11c, Mcp1, F4/80). 
     While research is lacking on the effects of grape anthocyanins specifically, 
anthocyanins from other dietary sources have been well documented in the literature.  
Anthocyanins have been demonstrated to consistently exert anti-inflammatory and anti-
obesity effects in vitro, and in some instances in vivo.  For example, anthocyanins from 
black soybeans reversed weight gain, reduced the levels of serum TG and cholesterol, 
and increased the levels of high-density lipoprotein (HDL) [46]. These findings are 
consistent with our data demonstrating that mice fed the anthocyanin-rich EP fraction had 
reduced body weight gain and plasma TG levels compared to the HF controls.  Also, 
anthocyanins from purple corn prevented HF diet induced increases in body weight and 
adipose tissue weights in mice [47]. Similarly, in HF (60% kcals from lard) fed mice, 
purified anthocyanins from blueberries prevented body weight gain and fat gain 
compared to controls [48].  Additionally, tart cherries, similar to grapes with respect to 
anthocyanin profile, reduced fat mass and WAT markers of inflammation including Il-6 
and Tnfα. [49].  These data are consistent with our data demonstrating that the 
anthocyanin-rich EP fraction decreased body weight gain, fat mass, plasma TG levels, 
and WAT expression of inflammatory markers including Tnfα, Mcp1, Cd11c, F4/80. 
Additionally, 3T3-L1 preadipocytes treated with anthocyanins had decreased TG 
accumulation and gene and protein expression of Pparγ and Fas [50]. While we did not 
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observe alterations in expression of Pparγ and Fas within the WAT, we did observe that 
mice fed the EP fraction had reduced expression of the lipogenic gene Agpat2. 
     We also demonstrated in this study that mice fed the anthocyanin-rich EP fraction had 
improved glucose tolerance and insulin sensitivity compared to the HF controls.  Similar 
effects of improvements in glucose tolerance were observed with supplementation of 
anthocyanins from Maqui Berry in HF fed mice [51] and also with supplementation of 
anthocyanins from Cornelian cherry in HF fed mice [52]. It has been reported that 
cyanidin-3-O-glucoside supplementation improves insulin sensitivity in diabetic mice via 
down-regulation of retinol binding protein and up-regulation of GLUT4 gene expression 
[53]. This could be a potential mechanism by which the EP fraction improved glucose 
tolerance and insulin sensitivity.  
     One novel finding of our study was that the anthocyanin-rich EP fraction increased 
expression of Hsl, a gene associated with lipolysis, and reduced expression the lipogenic-
related gene, Pparγ within the liver. This indicates that the EP fraction may reduce 
steatosis through up-regulation of lipolytic pathways and suppression of lipogenic 
pathways.  Further research examining the effect of the EP fraction on these pathways 
would be beneficial to better understand the mechanisms by which the EP fraction 
reduces adiposity or steatosis.   
 
Relationship of intestinal inflammation to systemic inflammation 
     High fat feeding is known to increase body fat mass and has been shown to 
consistently induce chronic, low grade inflammation systemically [reviewed in 54]. 
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However, the link between diet and intestinal inflammation has not been as extensively 
studied.  In the current study, HF feeding did not increase markers of inflammation in the 
ileum or proximal colon after 16 weeks, nor was there any beneficial effect of GP or 
grape fraction consumption.  However, other research has shown that HF diets can trigger 
intestinal inflammation or endotoxemia that may increase systemic inflammation, 
possibly due to intestinal dysbiosis and barrier dysfunction [7-13].  For example, mice 
fed a HF diet had increased levels of saturated fatty acids and lipopolysaccharide (LPS) 
within intestinal tissue samples resulting in increased Tnf-α and Il-6 expression through 
activation of the toll-like receptor (Tlr)4/(nuclear factor)Nf-κB signaling pathway [18].  
Mice fed a HF diet were also more susceptible to dextran sulfate sodium (DSS) induced 
colitis [19].  As a result the immune response was reduced which was associated with an 
increase in non-CD1d-restricted natural killer T (NK T) cells, which produce 
inflammatory cytokines similar to those secreted by adipocytes, decreasing the number of 
regular NK T cells normally found in the colon.  In addition, dietary supplementation 
with bioactive food components such as grape seed extract and red wine extracts has been 
shown to improve the intestinal health of subjects fed HF diets.   For example, chronic 
consumption of grape seed extract increases tight junction protein and reduces fecal 
calprotectin; a neutrophil protein used as a marker of intestinal inflammation [55], and 
attenuates inflammatory signaling in chemically-induced colitis [56]. Furthermore, in 
Wistar rats treated with concentrated grape juice, induced colitis was attenuated [57]. In 
the current study, consumption of the EP and EP+NEP fractions notably attenuated 
several proinflammatory markers in the WAT, but only EP+NEP decreased the 
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expression of the macrophage markers Cd68 in the proximal colon.  Although the activity 
of the neutrophil enzyme myeloperoxidase was decreased by 40-50% in the EP and 
EP+NEP groups compared to the HF controls, these differences were not statistically 
significant. However, measuring the protein levels of inflammatory markers and the 
activity of myeloperoxidase and alkaline phosphates in the colon may provide more 
insight. Alternatively, the intestinal linkage to systemic effects of HF and grape fraction 
feeding may be due to changes in gut microbiota, as indicated in our first study (Chapter 
III).  
     The intestinal microbiota is highly influenced by environmental changes which have 
been linked to alterations in host health and energy intake.  Research has shown that 
alteration to the gut microbiota by HF feeding can result in increased adiposity, insulin 
resistance and increased inflammatory cytokines and chemokines [58 -60].  This has been 
linked to impaired gut barrier function (i.e., the inhibition of tight junction protein 
production or reduction of mucin secretion from goblet cells) leading to endotoxemia 
[61,62] and impaired regulation of energy intake and metabolism through activation 
TLR-dependent enteroendocrine signaling pathways resulting in impaired neural 
response to leptin [reviewed in 63].  Conversely, microbial consumption of dietary fiber 
and polyphenols such as those found in grapes, may reduce intestinal and systemic 
inflammation through regulation of energy intake and improved intestinal barrier function 
[reviewed in 64].  Grape polyphenols in particular may have a major impact on the 
microflora of the large intestine. For example, red wine grape polyphenols given to 
humans for 4 weeks significantly increased the number of Enterococcus, Prevotella, 
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Bacteriodetes, and Bifidobacterium bacteria which correlated to improved blood 
pressure, and serum levels of TG, total cholesterol, and CRP [65].  Further evidence of 
the prebiotic effects of grape consumption can be seen in rats given grape pomace juice 
which increased fecal counts of Lactobacillus and Bifidobacterium which consequently 
also resulted in an increase in the concentration of primary bile acids, cholesterol, and 
cholesterol metabolites while decreasing the concentration of secondary bile acids [66].  
This suggests that alteration of the microflora by grape polyphenols may inhibit 
cholesterol absorption thus improving circulating levels. Indeed, fermentation of fiber 
and polyphenols by colonic microbes into SCFA has been shown to regulate energy 
intake and metabolism through stimulating the release of glycoproteins (e.g., Glp-1, Glp-
2, and Pyy) by activating Gpr43 and Gpr41 on enteroendocrine cells [reviewed in 67].  
Butyrate in particular is also beneficial to intestinal homeostasis as an endothelial energy 
source as well as through increasing tight junction protein synthesis and mucin secretions 
[68,69]. In the current study, the expression of several markers of enteroendocrine cell 
secretions associated with SCFA activation were upregulated.   However, these results 
were conflicting between the ileum (i.e., Gpr43 mRNA levels increased by the EP, NEP, 
EP+NEP diets) and the proximal colon (i.e., Gpr43 mRNA levels increased by HF diet 
only).  Future analysis of the intestinal microbiota composition, protein levels of Gprs, 
Pyy, and Glp1/2 levels, and gut barrier function should provide more insight about the 







Limitations and unanswered questions 
 
     The beneficial systemic effects of consuming the EP grape fraction may be due to its 
rich anthocyanin content.  However, the whole GP diet did not have the same positive 
outcomes as the EP or NEP diets.  There were several differences in the design of our 
previous (Chapter III) and current study that may have contributed to these conflicting 
results.  The previous research was shorter (10 weeks) compared to the current study (16 
weeks) and the diet composition with regards to fat (i.e., primarily butter fat at 34% kcals 
versus a combination of butter, lard, shortening, and beef tallow at 45% kcals from fat, 
respectively) and fiber (50 g versus 40 g cellulose, respectively). The additional 6 weeks 
in length of the current study may have caused any potential health benefits of the whole 
grape diet to have diminished. Yet, by week 10 of the second study, there were no 
differences between the HF and GP group in regards to body weight, body fat percentage, 
and glucose tolerance.  Furthermore, there may have been a different interaction between 
the GP and the four types of fats in the current study versus the sole fat source (butter) in 
the first study (i.e., the polyphenols in the  whole GP may interact with butter differently 
than with the other fat sources, thereby affecting their bioaccessibility and 
bioavailability). Indeed, the fat content of the diet can differentially impact polyphenol 
digestion and absorption [70].  Such an interaction may have enabled the polyphenols to 
inhibit lipase activity, possibly affecting the rate of fat absorption.  The increase in 
calories in the current study may have been too excessive for the beneficial effects of the 
whole GP to have a positive impact on lipid absorption as well.  In order to increase the 
percentage of fat in the current study, the amount of cellulose and corn starch were 
103 
 
reduced compared to the previous study. The alteration in carbohydrate and fiber content 
may have resulted more time for increased absorption of macronutrients. Such a scenario 
would result in greater energy harvest, adipogenesis, and triglyceride synthesis in the 
liver and WAT, independent of any effects by the grape powder.  Furthermore, the 
extraction process of the anthocyanin rich fraction may have increased the 
bioaccessibility and subsequent bioavailability of the polyphenols within the powder by 
liberating them from interactions within the food matrix, making them more susceptible 
to interactions with brush boarder enzymes potential enhancing their absorption in the 
small intestine.  Similarly, liberation of the polyphenols may have altered the luminal 
environment, thereby improving the confluence of beneficial bacteria. 
     Another possible impact of the reduced fiber may have been on the microbiota of the 
large intestine, as fiber is a primary energy source for a vast majority of microbes in this 
environment.  As such, the reduced fiber may impact the production of SCFAs as well as 
reduce the diversity of the microbiota, which typically results in intestinal inflammation, 
impaired barrier function, or adverse systemic effects.  Interestingly, although the GP diet 
had no positive health impact in the second study, the extractable polyphenol fraction did 
have a positive effect on reducing HF-mediated adiposity and systemic inflammation. 
Future studies should focus on feeding single anthocyanins and there combinations (i.e., 
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*LF, low fat control; HF, high fat sugar control; GP, grape powder; EP, extractable 
polyphenol fraction; NEP, non-extractable polyphenol fraction  
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Table 4.2. Phenolic Composition of Grape Powder (GP), Extractable Polyphenol 
(EP), and Non-Extractable Polyphenol (NEP) Fraction 
 
Assay GP EP NEP 
Weight percentage (%) 100 2.26 6.91 
Total phenolics1  9.13 180.0 ± 1.3  10.5 ± 1.02 
Total anthocyanins2  0.33 37.8 ± 1.8 ND 
Total proanthocyanidins3 (mg/g) 3.05 305.5 ± 7.0 ND 
 
1Total phenolics, mg/g DM as gallic acid equivalent (Folin Ciocaleau assay) 
2Total anthocyanins, mg/g DM as cyaniding glucoside equivalent (pH differential assay) 
3Total proanthocyanidins, mg/g DM as cyaniding glucoside equivalent (DMAC assay) 
107 
 
Table 4.3. Anthocyanin Concentration in Grape Powder (GP) and the Extractable 










1 Delphinidin-3-O-glucoside   4.93 
2 Pyanidin-3-O-glucoside   10.56 
3 Petunidin-3-O-glucoside   4.91 
4 Peonidin-3-O-glucoside   36.56 
5 Malvidin-3-O-glucoside  145.2 30.83 
6 Malvidin-3-O-(6"-O-acetyl-glucoside)   3.70 
7 Petunidin-3-O-cis-(6"-p-coumaryl-glucoside)   2.56 





10 Peonidin-3-O-cis-(6"-p-coumaryl-glucoside  31.7 2.73 















Table 4.4. Body Weight Gain (BWG), Food Conversion Efficiency (FCE), and Total 




*LF, low fat control; HF, high fat sugar control; GP, grape powder; EP, extractable 






Figure 4.1. Proanthocyanin Degree of Polymerization in EP Fraction. NP-HPLC-
FLD chromatogram (excitation 230 nm, emission 320 nm) for proanthocyanidins 






Figure 4.2.  Body Fat Percentages and WAT Depot Weights. Adiposity indices of 
C57BL/6J mice fed a low fat (LF),high fat (HF) diet, or a HF diet containing whole 
powdered table grapes (GP), the extractable polyphenol (EP) fraction from grapes, the 
non-extractable polyphenol (NEP) fraction from grapes, or an equal combination of the 
EP and NEP fractions (EP+NEP) for 16 weeks.  Body fat percentages were measured at 
weeks 6, 11, and 15 using dual energy x-ray absorptiometry (DEXA).  At week 16, the 
inguinal, retroperitoneal, epididymal, and mesenteric white adipose tissue (WAT) depots 
were excised and weighed.  The weights of the inguinal, retroperitoneal, epididymal, and 
mesenteric depots were measured, and their sum labelled total WAT.  Means ± SEM (n = 
9-10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 





Figure 4.3. Glucose Tolerance Tests,  HOMA-IR Index, and Plasma Triglycerides 
(A)Glucose tolerance tests (GTT)s , (B) the homeostatic model assessment of insulin 
resistance (HOMA-IR), and (C)plasma TG levels of C57BL/6J mice fed a low fat 
(LF),high fat (HF) diet, or a HF diet containing whole powdered table grapes  (GP), the 
extractable polyphenol (EP) fraction from grapes, the non-extractable polyphenol (NEP) 
fraction from grapes, or an equal combination of the EP and NEP fractions (EP+NEP) for 
16 weeks.  At weeks 7, 12, and 16, GTTs were conducted on mice fasted for 8 h and 
injected i.p. with a 20% glucose solution.  Fasting plasma insulin was collected at week 
16 and used to calculate the HOMA-IR index. Data are expressed as total area under the 
curve (AUC) for the GTTs. Means ± SEM (n=9-10) without a common lowercase letter 






Figure 4.4. Liver Markers of Inflammation and Lipid Metabolism. Liver gene 
expression of markers of inflammation, lipolysis, and lipogenesis in liver of C57BL/6J 
mice fed a low fat (LF), high fat (HF) diet, or a HF diet containing whole powdered table 
grapes (GP), the extractable polyphenol (EP) fraction from grapes, the non-extractable 
polyphenol (NEP) fraction from grapes, or an equal combination of the EP and NEP 
fractions (EP+NEP) for 16 weeks.  qPCR was conducted to measure mRNA abundance 
of genes associated with hepatic inflammation, lipolysis, or lipogenesis. Means ± SEM 
(n=9-10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 





Figure 4.5. Liver Weight, Triglycerides, and Oil Red O Staining. (A) Liver weights, 
(B) liver triglyceride content, and (C) Oil red O staining of liver tissue of C57BL/6J mice 
fed a low fat (LF), high fat (HF) diet, or a HF diet containing whole powdered table 
grapes  (GP), the extractable polyphenol (EP) fraction from grapes, the non-extractable 
polyphenol (NEP) fraction from grapes, or an equal combination of the EP and NEP 
fractions (EP+NEP) for 16 weeks. At week 16, liver tissues were excised and frozen in 
OCT compounds, cut at 5 μm, mounted on slides, and stained with Oil red O solution. 
Means ± SEM (n=9-10) without a common lowercase letter differ (p<0.05) using one-





Figure 4.6. Expression of Markers of Inflammation in WAT. The expression of 
markers of inflammation in (A) inguinal and (B) epididymal WAT of C57BL/6J mice fed 
a low fat (LF),high fat (HF) diet, or a HF diet containing whole powdered table grapes  
(GP), the extractable polyphenol (EP) fraction from grapes, the non-extractable 
polyphenol (NEP) fraction from grapes, or an equal combination of the EP and NEP 
fractions (EP+NEP) for qPCR was conducted to measure mRNA abundance of genes 
associated with inflammation in inguinal (A; subcutaneous) and epididymal (B; visceral) 
WAT depots. Means ± SEM (n=9-10) without a common lowercase letter differ (p<0.05) 





Figure 4.7. Expression of Markers of Lipid Metabolism in WAT. The expression of 
markers of lipogenesis, lipolysis, or fatty-acid oxidation in (A) inguinal and (B) 
epididymal WAT of C57BL/6J mice fed a low fat (LF), high fat (HF) diet, or a HF diet 
containing whole powdered table grapes (GP), the extractable polyphenol (EP) fraction 
from grapes, the non-extractable polyphenol (NEP) fraction from grapes, or an equal 
combination of the EP and NEP fractions (EP+NEP) for 16 weeks.  qPCR was conducted 
to measure mRNA abundance of genes associated with lipogenesis, lipolysis, and fatty-
acid oxidation in inguinal (A; subcutaneous) and epididymal (B; visceral) WAT depots. 
Means ± SEM (n=9-10) without a common lowercase letter differ (p<0.05) using one-





Figure 4.8. Expression of Markers of Intestinal Inflammation.  The expression of 
markers of inflammation in the (A) ileum,  (B) proximal colon, and the  (A) activity of 
myeloperoxidase in the mucosa of C57BL/6J mice fed a low fat (LF),high fat (HF) diet, 
or a HF diet containing whole powdered table grapes  (GP), the extractable polyphenol 
(EP) fraction from grapes, the non-extractable polyphenol (NEP) fraction from grapes, or 
an equal combination of the EP and NEP fractions (EP+NEP) for 16 weeks.  qPCR was 
conducted to measure mRNA abundance of genes associated with inflammation in ileum 
mucosa and proximal colon mucosa.  Means ± SEM (n=9-10) without a common 






Figure 4.9. Expression of G-Protein Receptors and Glycoproteins in Intestinal 
Mucosa.  The expression  of G-protein receptors (Gpr) 41 and 43, peptide YY (Pyy), and 
glucagon like protein (Glp) were measured as markers of SCFA regulation in the (A) 
ileum and (B) proximal colon mucosa of C57BL/6J mice fed a low fat (LF),high fat (HF) 
diet, or a HF diet containing whole powdered table grapes  (GP), the extractable 
polyphenol (EP) fraction from grapes, the non-extractable polyphenol (NEP) fraction 
from grapes, or an equal combination of the EP and NEP fractions (EP+NEP) for 16 
weeks.  qPCR was conducted to measure mRNA abundance of genes associated with 
regulation of energy intake in ileum mucosa and proximal colon mucosa.  Means ± SEM 
(n=9-10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 
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Summary of Findings 
     The prevalence of obesity has reached epidemic levels worldwide, and is associated 
with excess energy consumption and low levels of physical activity [1].  The numerous 
health consequences associated with obesity such as cardiovascular disease, 
hypertension, and type 2 diabetes are referred to as the metabolic syndrome [2].  
Increased adiposity due to adipocyte hyperplasia or hypertrophy initiates inflammatory 
signaling that can result in impaired insulin signaling and other metabolic complications 
[3]. Because of the great prevalence of these conditions, identification of dietary 
strategies to prevent and treat obesity is warranted.  
     One potential way to combat chronic inflammation and health complications 
associated with diet-induced obesity is through consumption of polyphenol-rich table 
grapes.  Grapes and grape products have been demonstrated to reduce oxidative stress, 
inflammation, and insulin resistance and improve heart health [4, 5, 6].  However, the 
mechanisms by which they exert these beneficial effects and the specific compounds in 
grapes responsible for mediating these effects remain in question.  While grapes are rich 
in polyphenols, their bioavailability is poor, estimated to be less than 5%.  Because of 
this, it is hypothesized that the polyphenols and fiber in grapes reach the cecum and colon
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and impact gut microbial populations that in turn are responsible, in part, for the observed 
systemic health benefits.  It has been demonstrated that grape products or several of their 
components increase beneficial microbial species including Lactobacillus spp. and 
Enterococcus spp. [7, 8].  Additionally, gut microbial fermentation of grape polyphenols 
and fiber may result in short chain fatty acid (SCFA) production, some of which may 
improve colonocyte health, reduce inflammation, and improve insulin sensitivity 
[9,10,11,12].   
     However, the bioavailability of grape polyphenols and the interactions with gut 
microbes are still in question, as is their influence on diet-induced obesity.  Therefore, I 
investigated the following two specific aims;  
     Aim #1) Determine the extent to which California table grapes attenuate body fat 
accumulation, systemic inflammation, insulin resistance, and impact gut microbiota in 
mice fed an American type diet rich in butter (CHAPTER III); and  
     Aim #2) Identify the key bioactive fraction(s) responsible for reducing adiposity, 
inflammation, and insulin resistance, and modulating gut microbiota in mice fed an 
American type diet rich in four types of saturated fat (CHAPTER IV).  
     The results of the first study demonstrate that consuming one or both levels of table 
grapes (3-5%, w/w) attenuated the accumulation of body and liver fat in mice fed a diet 
rich in butter (i.e., 35% kcals from fat, most from butter; and amount of fat similar to the 
50th percentile of American fat consumption) compared to control mice. However, these 
lipid-lowering effects were not associated reductions in markers of inflammation in white 
adipose tissue (WAT) or improvements in glucose tolerance.  Interestingly, populations of 
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the deleterious sulfidogenic bacteria Desulfobacter spp, and the Bilophila wadsworthia-
specific dissimilatory sulfite reductase gene were decreased by grape consumption and 
populations of the beneficial bacterium Akkermansia muciniphilia tended to be higher in 
grape-fed mice compared to their respective controls.  These data indicate that grape 
consumption (3 or 5%, equivalent to 9–15 servings) is effective in attenuating adiposity 
and hepatic steatosis, and altering gut microbial composition in mice fed a butter-rich diet.  
In the second study, it was observed that in mice fed a high fat American type diet (i.e., 
45% kcals from a mixture of lard, shortening, butter, and beef tallow, which was equivalent 
in fat amount and type to the 75th percentile of American fat consumption), the extractable 
polyphenol fraction (EP) alone or when combined with the non-extractable polyphenol 
fraction (EP+NEP) reduced adiposity, liver and plasma triglycerides, mRNA markers of 
inflammation within WAT, and improved insulin sensitivity compared to the high-fat fed 
controls. The EP fraction is abundant in polyphenols, primarily anthocyanins, which I 
hypothesize are responsible for the beneficial outcomes observed. However, the 
mechanisms by which the EP fraction exerts these effects on adiposity, insulin sensitivity, 
hepatic steatosis, and inflammation remain unclear.   
     One unexpected outcome observed in the second study was that the 5% grape diet fed 
adversely impacted some of the outcomes (i.e., decreased glucose disposal and increased 
adiposity and inflammatory markers). The differences in the effectiveness of grape powder 
diet between the first and second study may be due to several factors.  First, the high fat 
diet in the first study consisted of 34% fat (of total kcals) primarily from butter, while in 
the high fat diet in the second study consisted of 45% fat (of total kcals) from a combination 
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of lard, shortening, butter, soybean oil, and beef tallow.  These differences in the fat content 
and source may have contributed to the differences observed in the effectiveness of the 
grape powder diet.  In the second study, while the grape powder diet (GP) contained the 
same amount of polyphenols that are in the grape fraction diets (i.e. HF-EP, HF-NEP, and 
HF-EP+NEP), we did not observe the health benefits with the grape powder diet that we 
did with the fraction diets.  It has been demonstrated that certain fibers and proteins interact 
with polyphenols and can make them either more or less bioaccessable [13].  Therefore, it 
is possible that the acidified methanol extraction process used to obtain the EP and NEP 
fractions liberated the polyphenols from the fiber or other components (e.g., proteins) they 
are bound to, thereby making them more bioaccessable. However, further research is 
needed to determine if the extraction process indeed makes the polyphenols more 
bioaccessable, and thus more bioavailable.  We did not attempt to measure the polyphenol 
profile in the plasma of mice consuming EP, NEP, or GP because we anticipated that the 
plasma levels would be undetectable due to our mice being fasted and the knowledge from 
a previous study indicated that polyphenol levels spike within the first 3 hours following 
ingestion [6]. One possible future study would be to gavage mice with EP, NEP, or GP and 
collect blood 1-3 hours post gavage to use for examination of polyphenol content.  While 
this would help greatly in providing information on the bioaccesability of the polyphenols 
in GP and its fractions, it would require a great deal of resources due to the expense of 
instrumentation and number of polyphenol standards that would have to be purchased for 




Future Data Collection 
     In order to answer some of the remaining questions in CHAPTER III and CHAPTER 
IV, additional analysis are warranted as follows:.  (i) In CHAPTER IV, mesenteric WAT 
gene expression and lipid metabolism, (ii)microbial profile and SCFA composition in the 
cecum, (iii) immunohistochemistry of the tight junction protein ZO-1 in the ileum, and (iv) 
examination of protein levels of 5’ adenosine monophosphate kinase (AMPK) and genes 
that were altered by grape and grape extract treatments.   
 
Future Research 
     Based on the findings in CHAPTER III and CHAPTER IV, pursuit of the following 
research questions is warranted: (i) Which specific anthocyanins present in the EP fraction 
are the most effective in preventing the negative effects of diet-induced obesity?; (ii) Is the 
EP fraction and specific anthocyanins within it effective in reducing adiposity and insulin 
resistance in subjects that are already obese (i.e., can it be used as a treatment for obesity 
versus as a prevention in the current study)?, (iii) What metabolites of grape polyphenols 
are being produced by the gut microbiota and are they responsible for the reductions in 
inflammation, adiposity, and insulin resistance?, and (iv) What was the reason for the 
discrepancies between the studies with regards to the differential effects of grape powder 





Q1. Which specific anthocyanins present in the EP fraction are the most effective at 
preventing the negative effects of diet-induced obesity? 
     Our data showed that the EP fraction from grapes was more effective than the NEP or 
whole grape diet in preventing adiposity, insulin resistance, systemic inflammation, and 
hepatic steatosis in mice fed an American-type, high fat diet (i.e., 45% kcals from fat with 
a mixture of saturated fatty acids).  The EP fraction contains many different anthocyanins 
in differing amounts and thus examination of their individual effectiveness is needed.  To 
examine this, I propose an in vitro screening of individual anthocyanins for suppression of 
NF-kB activity, as conducted by Chuang et al. [14]. Primary cultures of human adipocytes 
will be transiently transfected with a NF-kB responsive luciferase reporter construct.  Cells 
will be pretreated with vehicle or three different doses of malvidin, cyanidin, or peonidin 
for 1 h and then treated with or without 100 ng/mL TNFα for 24 hours.  Measurement of 
firefly luciferase activity relative to control renilla luciferase activity will be used to 
determine the effect of the anthocyanins treatment on suppression of NF-kB activity.  The 
outcomes of this experiment will demonstrate which anthocyanins present in grapes 
exhibits the greatest anti-inflammatory effects in primary adipocytes.  Subsequently, the 
most effective candidate anthocyanins identified using this screening strategy would be 
included in the diets of high fat fed mice alone or in combinations and the outcomes 





Q2. Is the EP fraction and specific anthocyanins within it effective in reducing adiposity 
and insulin resistance in obese subjects? 
     The number of individuals who are overweight or obese and exhibit symptoms of the 
metabolic syndrome is at epidemic levels in the U.S.  Our previous data showed that the 
EP fraction exerted the greatest impact on preventing diet-induced obesity and related 
complications in mice fed a high fat diet.  Because this was a preventative model (i.e., mice 
were given the high fat diet at the onset of the study rather than after they gained body fat 
and became insulin resistant), it doesn’t take into account the effect on individuals who are 
already obese.  Therefore, a model of the effects of the EP fraction on reducing the effects 
of diet-induced obesity in mice that are already obese and exhibiting symptoms of the 
metabolic syndrome would be beneficial to provide data from a treatment perspective.  To 
examine this question, I would employ a 16 week study using C57BL/6 mice fed a low fat 
(LF) or a high fat (HF) American type diet for 6 weeks to make them overweight and 
insulin resistant, as described by Shen et al [15]. Subsequently, mice would by 
randomization into various treatment groups for the remaining 10 weeks as follows: LF, 
HF, HF plus anthocyanin #1, HF plus anthocyanin #2, HF plus anthocyanin #1 and #2, and 
HF plus EP.  The most effective anthocyanins identified through exploration of Q1 will be 
utilized as “anthocyanin #1” and “anthocyanin #2” in this study.  At the end of the study, 
mice will be killed and WAT, liver, intestines, and plasma will be collected and used for 
analysis, as described in CHAPTER III and IV. The outcomes of this experiment will 
provide information on the effectiveness of grape anthocyanins on treatment of diet-
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induced obesity as well as identify which grape anthocyanins are most effective at 
attenuating diet-induced obesity and associated complications in vivo. 
 
Q3. What metabolites of grape polyphenols are being produced by the gut microbiota and 
are they responsible for the reductions in inflammation, adiposity, and insulin resistance? 
     Our data demonstrated that feeding grapes or their methanol-extractable fractions alters 
the gut microbial populations in mice fed a high fat diet.  Research has illustrated that 
anthocyanins are not readily bioaccessable or bioavailable [16].  Because of this, it can be 
hypothesized that the gut microbiota are interacting with the grape anthocyanins to produce 
metabolites that may be responsible for reducing inflammation, adiposity, insulin 
resistance, or hepatic steatosis.  It has been observed that metabolites of anthocyanins such 
as gallic acid and syringic acid are indeed bioavailable and possess anti-inflammatory and 
antioxidant properties [17].  To explore the metabolite production by gut microbiota in 
response to grape polyphenols, I propose an in vitro model.  The specific beneficial 
bacterial strains identified to be altered upon anthocyanin feeding in Q2 will be cultured 
and exposed to candidate anthocyanins alone, or the EP fraction of grapes.  Growth of the 
bacteria will be monitored over 24 hours and then the conditioned media will be collected 
and analyzed for metabolite composition.  Subsequently, the conditioned media will be 
used for treatment of primary human adipocytes transfected with a NF-kB responsive 
luciferase reporter construct to examine its effect on inflammation, as discussed in detail 
in Q1. The outcomes of this experiment will identify the metabolites produced by 
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beneficial bacterial strains in response to grape anthocyanin exposure as well as the 
effectiveness of these metabolites on suppressing inflammation. 
 
Q4. What was the reason behind the discrepancies between the two studies in regards to 
the differential effects of grape powder on body fat, insulin sensitivity, and inflammation? 
     In the first study (CHAPTER III), our data demonstrated that feeding grape powder at 
one or both levels (i.e., 3% or 5% w/w) in conjunction with a high fat diet (i.e.34% of kcal 
primarily from butter) reduced body fat, and reduced markers of inflammation in WAT.  
However, in the second study feeding grape powder at the 5% level in conjunction with a 
high fat diet (i.e. 45% of kcal from mixed sources) did not result in improvements in body 
fat, insulin sensitivity, and inflammation.  This may be due to several different factors 
including; (i) the differences in fat content and composition, (ii) the length of the studies, 
and (iii) the diet formulation process.   
     With the first study, the fat content of the HF diets was 34% of total kcals primarily 
from butter, while in the second study the HF diets contained 45% of total kcals from mixed 
sources of fats, representative of the fat distribution of a typical American diet.  These 
differences in fat content and sources may have contributed to the differences we observed 
in the effectiveness of the grape diets between the first study and the second study.  It is 
possible that the inflammatory and lipogenic response was much greater in the 45% kcal 
from mixed fats diet and that the effect of grape feeding was not able to overcome this 
increased response like it did in the 34% kcal from butter fat fed mice.     
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     The differences in length of the two studies may also explain some of the data we 
observed in the GP group.  The duration of the first study was 11 weeks and we did observe 
improvements in adiposity and markers of inflammation with the 5% grape fed mice while 
the second study was 16 weeks and we did not observe any improvements in inflammation 
or adiposity in the mice fed the same amounts of powdered grapes.  During the second 
study, we did harvest three animals per treatment at week 12 and found that the gene 
expression of inflammatory markers (i.e. Mcp1, F4/80, Cd11c) in WAT was not as robust 
in the GP group as what we observed in animals harvested at week 16.  This may indicate 
that the powdered grape diet has a more acute rather than chronic effect on inflammation.  
Consistent with this finding, it was previously shown that GP supplementation (i.e 3% 
w/w) to a HF diet (i.e 60% of total kcals from fat) results in improvements in glucose 
tolerance at week 5 but not at weeks 10 and 15 [6].   
     Additionally, because we did not make the diets ourselves, it is possible that during the 
diet formulation process the mild amounts of heat and mixing used during pelting of the 
diet may have introduced variation or altered the compounds present in our GP diets.  We 
did attempt to have the diets analyzed for phenolic content after they were made, but were 
unsuccessful.  This may be due to the amount of fat in the diets that may interfere with the 
ability to isolate and detect phenolic compounds.  To eliminate this potential confounding 
variable, in future studies using daily oral gavage of the EP, NEP, and GP components 
would ensure that these compounds are delivered to each mouse in the same dosage and 





     In summary, there is still much to be elucidated concerning the bioaccesability, 
bioavailability, and metabolic actions of grape polyphenols on attenuation of diet-induced 
obesity, chronic inflammation, insulin resistance, and hepatic steatosis.  Additionally, it is 
necessary to understand the way in which these polyphenols interact with gut microbiota 
to produce metabolites that may be more bioavailable and thus responsible for the 
prevention of adiposity, insulin resistance, and inflammation associated with consumption 
of a high fat diet.  The proposed studies will help in answering these questions which will 
allow for the development of dietary means by which to use grapes or their components to 
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